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This thesis developed from my period as Research Fellow with the Scottish 
Intracranial Vascular Malformation Study (SIVMS), now known as the Scottish 
Audit of Intracranial Vascular Malformations (SAIVMS), a post held from April 
2002 until August 2004. SIVMS was the first prospective, population-based study of 
the major types of intracranial vascular malformations; arteriovenous, cavernous and 
venous malformations including dural fistulae and carotid-cavernous fistulae. It was 
based in Scotland and designed in 1998 by my supervisor Professor Charles Warlow 
and the first Research Fellow Dr Rustam Al-Shahi supported by the SIVMS steering 
committee (www.saivms.scot.nhs.uk). Recruitment and follow-up began in January 
1999. Recruitment and follow-up of all vascular malformation types was done by Dr 
Al-Shahi until March 2002 and this role then transferred to me in April 2002 until I 
left in August 2004. The main duties of the Research Fellow were to collect and 
review all the clinical material of cases notified to SIVMS and arbitrate with the 
relevant expertise where there was doubt whether the case met the criteria for 
inclusion in SIVMS. Apart from my clinical responsibilities in recruitment and 
follow-up, the post also involved supervision of the part-time study administrator and 
also weekly meetings with the study programmer. I was also responsible for 
convening and presenting updates of the study progress weekly to my supervisor 
Professor Charles Warlow, biannually to the Study steering committee meetings, and 
annually to my funding body, the Stroke Association. This Research Fellowship also 




interest in a long running study and I made presentations to improve the profile of the 
study on the national and international stage. 
 
For my duration as the SIVMS Research Fellow, I recruited and followed-up all 
types of newly diagnosed intracranial vascular malformations (IVMs). This thesis, 
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(ICMs) recruited to the study by both Dr Al-Shahi and myself between January 1999 
and December 2003. The follow-up data in this thesis were that available to me on 
August 31
st
 2004. The data cleaning and the analysis for this thesis has been 
performed by me alone under the supervision of Professor Warlow. 
 
Although the core study design was well-established and tested prior to my 
involvement with SIVMS, I did divise new studies such as the Sensitivity and 
Specificity of MRI in the diagnosis of intracranial CMs. This cavernoma imaging 
study was a separate study designed, executed and analysed by myself, a medical 
student Sue Liong, the Cavernoma Imaging Study Group [appendix 1] with guidance 
from Professor Warlow, Dr Al-Shahi, Dr Andrew Farrall (consultant 
neuroradiologist) and Dr Steff Lewis (Medical Statistician). Computing support was 
provided by Aidan Hutchison (SIVMS programmer). 
 
The writing of this thesis has been done by me alone under the supervision of 




thesis. All graphs, tables and figures have been created by me unless a clear 
acknowledgement lies underneath.  
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untreated clinical course of cavernomas which has been published by Lancet 
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Background: Intracranial cavernous malformations (cavernomas) are an abnormal 
collection of dilated vascular channels in the brain. Their aetiology is complex and 
largely unknown but they can cause significant morbidity and mortality in terms of 
epilepsy, haemorrhage and focal neurological deficit (FND). The histopathology and 
also MR imaging characteristics are well described but the validity of MR as a 
diagnostic tool has never been evaluated. 
Aims of this thesis: 1. To systematically review the literature on intracranial 
cavernous malformations in adults. 2. To establish the incidence, presentation and 
early untreated prognosis of intracranial cavernous malformations in a population-
based study of adults in Scotland. 3. To evaluate the validity of MR imaging as a 
diagnostic tool for intracranial cavernomas. 
Methods: A systematic, electronic search of the literature was carried out initially 
and all relevant articles were reviewed. The incidence, presentation and early 
prognosis of cavernomas were estimated in a cohort recruited to the Scottish 
Intracranial Vascular Malformation study (SIVMS) between January 1999 and 
December 2003. The sensitivity and specificity of MR imaging was estimated in an 
independent study of pathologically verified cavernomas and imaging mimics.    
Results: Systematic review of the literature revealed a paucity of methodologically 
robust evidence on the natural history of intracranial cavernomas in adults. The 
incidence of intracranial cavernomas in adults in SIVMS was 0.67 (95% CIs, 0.56 to 




of frequency were; asymptomatic (47%), epilepsy (25%), focal neurological deficit 
(15%) and haemorrhage (13%). Being female or presenting with haemorrhage or 
FND appear to increase the risk of having a haemorrhage or FND during early 
follow-up. The all cause mortality in SIVMS was 13% at three years. The sensitivity 
and specificity of MR imaging varied between 58-83% and 67-100% respectively. 
Conclusions: Intracranial cavernous malformations are rare lesions but have a 
significant morbidity and mortality associated with their diagnosis. MR is a valid 
diagnostic and screening tool for intracranial cavernomas.
















1.1 Intracranial cavernous malformations (cavernomas) 
Stroke is the third biggest cause of death in the UK and the largest single cause of 
severe disability [National Stroke Strategy, 2007]. Twenty-five percent of strokes are 
in people under the age of sixty-five. Strokes in young people are devastating not 
only for the victim but also their family. Intracranial cavernous malformations are 
one of the more rare causes of these debilitating events. They have also been 
responsible for the high profile death of an American track and field athlete Florence 
Griffith-Joyner in 1998 due to sudden unexpected death caused by epilepsy. To date 
the natural history of these lesions remains shrouded in mystery and their 
significance in terms of prevalence in a population is also unclear. This has been the 
inspiration for this thesis which focuses solely on intracranial cavernomas. 
 
Histopathology has been, and remains, the gold standard in the diagnosis of 
intracranial cavernous malformations. There is consensus about many histological 
features of cavernomas but there is also a long running debate in the literature about 
one feature that, supposedly, distinguishes cavernomas from capillary telangiectases. 
In this chapter I will set the scene with an overview of the contribution 
histopathology makes to the diagnosis of cavernomas and, also, the literature on 
ultrastructure and immunohistochemistry. I will also review current views on the 
aetiology of intracranial cavernous malformations and the modern diagnostic 
techniques now available.  
 





Intracranial vascular malformations are often macroscopically described as 
mulberry-like structures which microscopically are found to be composed of a 
collection of dilated vascular channels (figures 1 & 2). 
 








Figure 2 Microscopic appearances of a brain cavernoma 
 
 
These channels are described as thin walled structures lined by a single layer of 
endothelium but lacking a basement membrane, elastin and also smooth muscle. 
They are not encapsulated lesions but are well circumscribed closely knit structures 
that are surrounded by gliotic brain tissue and a variable amount of haemosiderin-
laden macrophages [McCormick, 1966], [Simard, 1986], [Jellinger, 1986],  
[Zabramski, 1999] and [Raychaudhuri, 2005]. They also contain a variable amount 
of calcification and blood in various stages of thrombosis. 
 
Discussion or disagreement in the literature arises over the necessity for the lack or 
presence of brain parenchyma interwoven with the vascular channels as a 
distinguishing feature between cavernomas and capillary telangiectases. The case for 




the absence of intervening brain parenchyma in cavernomas was first presented by 
Virchow in the mid 19
th
 century [Virchow, 1851]. 
 
Support for it has been given throughout the years [Bergstrand, 1936], [Russell & 
Rubenstein, 1977], [McCormick, 1966], [Simard, 1986], [Jellinger, 1986], 
[Zabramski, 1999] and [Raychaudhuri, 2005]. These authors all subscribe to the 
present scheme of classifying vascular malformations which identifies cavernomas 
and capillary telangiectases as distinct entities. The only real reported histological 
difference between the two is the absence of intervening brain parenchyma in 
cavernomas and that is why this assumes such significance in classification systems. 
As  group, they acknowledge the existence of mixed vascular malformations but 
cannot decide whether they constitute a group of lesions that represent transitional 
forms between the different types of malformations with a common pathogenesis or, 
simply, that they signify the occasional coexistence of two different malformations in 
the same location. Some clinical differences between cavernomas and capillary 
telangiectases are also mooted which will be discussed later.  
 
The main reasons cited for not placing both these lesions into one group are 
1. The presence of larger, developmentally older lesions (i.e. cavernomas) in 
younger patients. 
2. The presence of enlarged draining veins among most capillary telangiectases 
and an absence of similar veins among cavernous lesions 




3. The tendency to haemorrhage which is restricted almost exclusively to 
cavernous malformations 
4. The occasional presence of capillary telangiectases which are larger than 
cavernomas when they coexist.  
 
The presence of intervening brain parenchyma in cavernomas was first published by 
Russell (1931) who suggested that capillary telangiectases could be precursors of 
cavernous malformations [Russell, 1931]. Her suggestion, that cavernomas were 
formed from the fusion of adjacent capillary loops, was a hypothesis also embraced 
by others who cited examples of a spectrum of transitional lesions between the two 
entities and also the frequent co-existence of the two lesions in a particular patient 
[Sjovall, 1938] & [Wyburn-Mason, 1944]. These authors believe that it is possible to 
have interwoven brain parenchyma within the core of cavernous malformations. 
More recently, work published by Rigamonti and others stressed the common ground 
between the two groups [Rigamonti, 1987] & [Rigamonti, 1988]. Their specimens 
depicted the commonly reported mass of closely packed, sinusoidal-type vessels 
devoid of elastic and muscular fibres [Bogren, 1970], [McCormick, 1984], 
[Stehbens, 1972], [Zulch, 1965]. Iron deposition in macrophages and glial cells in 
and around the vascular lesion and evidence of thrombosis, calcification, 
haemorrhage, inflammatory changes and ossification were identified in decreasing 
frequency, consistent with published data [McCormick, 1984], [Russell Rubenstein, 
1977] & [Stehbens, 1972].  
 




What was more interesting was the frequency with which brain parenchyma was 
found between the abnormally dilated vascular channels in Rigamonti’s cohort - it 
was high at 35%. This allowed Rigamonti to suggest that the transitional forms 
between cavernomas (CMs) and capillary telangiectases are more frequent than 
previously thought and, therefore, that the division of CMs and capillary 
telangiectases into separate categories is arbitrary and inaccurate. He suggested that 
capillary telangiectases and cavernomas represent the ends of a spectrum of a single 
pathological entity and, therefore, proposed grouping them in a single category 
termed cerebral capillary malformations. Work by Tomlinson et al [Tomlinson, 
1994] and also Frischer et al [Frischer, 2008] support Rigamonti’s finding of 
intervening brain parenchyma in lesions otherwise classified as cavernous 
malformations.  
 
The arguments set out by the authors rallying against the need for the presence of 
intervening brain parenchyma are answered as follows: 
1. Enlarged draining veins seen in association with capillary telangiectases but 
not with CMs [Blackwood, 1941] & [Russell Rubenstein, 1977]: This is now 
known to be false [Rigamonti, 1991], [Numaguchi, 1977].  
2. The tendency of CMs only to bleed and cause important clinical symptoms 
[Russell Rubenstein, 1977]: This too is unsound as telangiectases can 
occasionally cause symptoms [McCormick, 1968] & [Teilmann, 1953].  




3. Smaller lesions do not always have the telangiectatic pattern when multiple 
lesions are present. Rigamonti argues that this is because smaller vascular 
malformations most likely represent an early transitional form. 
4. The presence of larger, developmentally older lesions (i.e. cavernomas) in 
younger patients: In the autopsy case from Rigamonti’s series, two CMs 
coexisted with 2 transitional capillary telangiectases, confirming the co 
existence of these two lesion types [Roberson, 1974] & [Russell Rubenstein, 
1977]. 
 
Although the case looks more and more convincing that from a pathological point of 
view perhaps these vascular lesions should be reclassified, Robert Solomon who 
comments on Rigamonti’s article made the valid point that reclassifying these lesions 
into the same group was not necessarily clinically helpful as currently telangiectases 
are not surgically removed but cavernomas in the correct clinical setting can be 
reasonably safely excised [Rigamonti, 1991]. Therefore reclassifying based on 
pathological definitions could serve the purpose of muddying the clinical waters in 
appropriately selecting cases suitable for surgery/treatment. 
 
While there is consensus about most histopathological features of cavernomas there 
is still disagreement about the distinction between cavernomas and capillary 
telangiectases. This is mainly because the pathogenic mechanisms leading to 




cavernomas are still shrouded in mystery. Much promise exists in this area, however, 
as a result of discoveries over the last 10 years, as discussed later.  
1.1.2 Ultrastructural features of intracranial cavernous malformations 
Merely three main studies have been published on the ultrastructural appearance of 
cavernous malformations [Wong, 2000], [Clatterbuck, 2001] and [Tu, 2005]. They 
include data from 3, 2 and 9 lesions respectively. Although the numbers are small 
they throw up potentially interesting features that may contribute to our 
understanding of the pathogenesis.  
 
The cerebral microvasculature or blood-brain barrier(BBB) is a unique and essential 
structure that consists of the interplay of three major microvascular components. 
Tight junctions between endothelial cells constitute the major permeability barrier, 
and the overall biology of the barrier is shaped by the paracrine interactions of the 
endothelium with the pericytes/smooth muscle cells and the astrocyte foot processes 
that cover most of the abluminal surface of the microvasculature [Pardridge, 1999]. 
What all these studies suggest is that abnormalities of the blood brain barrier are 
important in the pathophysiology of cavernous malformations. 
 
In blood-brain barrier (BBB) capillaries, endothelial cells are joined by continuous 
tight junctions produced in response to signals from astrocytes. In their small series 
Wong and others compared and contrasted cavernomas and arteriovenous 
malformations (AVMs) and demonstrated that, unlike AVMs, cavernomas have an 




immature BBB with absent tight junctions between endothelial cells, no astrocytic 
foot processes and rare pericytes. This finding was reproduced by Clatterbuck et al 
and, interestingly, when Tu et al compared haemorrhagic cavernomas with non 
haemorrhagic cavernomas these deficient tight junctions were only present in 
haemorrhagic lesions. This raises the possible mechanism whereby low flow vascular 
lesions such as cavernomas bleed regularly and also provides a possible theory about 
how they grow by recurrent small bleeds. 
 
These studies have also recorded haemosiderin staining in the tongue of normal brain 
tissue surrounding the lesion – presumably a blood breakdown product from frequent 
intermittent bleeds or leaks from the lesion. The absence of the basal lamina is also 
noted by Tu et al which is usually a feature of developing or immature capillaries. 
This was not a feature of Wong’s study but he did remark on the abnormality of the 
present basal lamina.  
 
Early studies of cavernoma ultrastructure raise interesting theories about the potential 
pathogenesis of these lesions. Further similar work on larger case series should be 
helpful but electron microscopy is a costly and time consuming exercise and not 
strictly necessary for the management of patients in the short term. Therefore we 
may have to await this kind of study for some time. 
 





There is an abundance of work on various proteins and growth factors in the 
literature on cavernomas, for example [Frim, 1996], [Robinson, 1995], [Rothbart, 
1996] and [Notelet, 1997], but none have as yet provided a unifying theory for the 
pathogenesis of cavernomas. Therefore I think it is sufficient to acknowledge that 
this work is ongoing and someday may contribute to the bigger picture of cavernoma 
development/aetiology. One facet of this work that I do want to highlight is a study 
of the expression of oestrogen and progesterone receptors in cavernomas [Kaya, 
2009]. There is a lot of literature constituting case reports and case series with small 
numbers, which suggest a relationship between pregnancy or hormonal therapy and 
the increased haemorrhage rate and seizure expression of cavernomas. In this context 
the study by Kaya et al [Kaya, 2009] was the first to look at the expression of the 
relevant hormonal receptors within cavernomas themselves as a way of explaining 
this phenomenon but they found no  expression of oestrogen or progesterone 
receptors in any of the 12 cerebral cavernomas they examined.   
 
1.1.4 Developmental venous anomalies or venous malformation (VM) 
This is another form of intracranial vascular malformation. VMs are not abnormally 
formed venous channels but merely dilated vessels. In isolation they are of little 
consequence [Hon JM,  2009] but as will be apparent later in my thesis a proportion 
of cavernomas are associated with a venous malformation (figure 3). The main 




significance of this is that the presence of both a CM and VM can make surgical 
excision more difficult. It suffices at this point just to know of their coexistence.  
 
Figure 3 A venous malformation (arrow heads) accompanying a cavernoma 




1.2.1 Familial and sporadic cases 
Previously it was thought that cavernomas were congenital lesions but this is now 
known not to be the case and this has significant implications for the estimation of 
lesion haemorrhage rates, as will be discussed later [Detwiler, 1997 & Zabramski, 
1994]. In the last ten years there have been great strides in the mammoth task of 




understanding the aetiology of cavernous malformations. It has seen the discovery of 
three genes involved in the familial form of the disease. Sporadic cases also occur, 
and cavernomas can develop de novo after treatment with radiotherapy anywhere 
from 2 to 20 years later. More often than not familial forms of the disease have 
multiple lesions of varying size and also varying symptomatology often within the 
same patient. There is well documented evidence of the dynamic nature of 
cavernomas in these patients. The size of documented lesions can increase over time 
with or without haemorrhage [Zabramski, 1994]. New lesions also appear over time 
[Zabramski, 1994]. It is now well established that familial cavernomas have an 
autosomal dominant pattern of inheritance with incomplete clinical and also 
neuroradiological penetrance. In the last 15 years three cerebral cavernous 
malformation (CCM) genes have been identified; CCM1/KRIT1 (chr 7q), CCM2 
(chr 7p) and CCM3 (chr 3q) in decreasing order of frequency [Gunel, 1996], 
[Bergametti, 2005], [Laberge, 1999], [Sahoo, 1999], [Sahoo, 2001] and [Eerola, 
2001]. A strong founder effect has been detected in Hispanic-American patients with 
cavernomas, with most families linked to the CCM1 locus [Gunel, 1996]. So far 
more than 150 distinct CCM1/2/3 germline mutations have been published [Riant, 
2010]. More than 90 of those are mutations of the CCM1 gene and the remainder are 
divided between mutations of both the CCM2 and CCM3 genes. The proteins 
encoded by all three CCM1-3 genes, KRIT1, MGC4607 and PDCD10 have been 
identified but their detailed functioning is still not entirely clear. It appears however 
that ‘loss of function’ is the most likely pathophysiological mechanism resulting 
from these germline mutations. 




Because cavernoma inheritance is autosomal dominant, the question arises what 
makes lesions occur focally and in multiple sites in the familial cases? Most groups 
subscribe to the theory of ‘Knudson’s two hit’ mechanism. A somatic mutation, 
possibly acquired in the embryonic or postnatal period, adds to the germline mutation 
resulting in the complete loss of the two alleles. Interestingly, somatic mutations 
occur only in endothelial cells and not in the intervening neural tissue. Also, not all 
endothelial cells of the lesion carry the somatic mutation. Therefore, it seems that 
lesions are comprised of a mosaic of wild-type and mutant endothelial cells. 
 
Recent identification of proteins that interact with one or more of the CCM1, CCM2 
and CCM3 proteins suggest that they influence angiogenesis in some way. Also 
CCM1 and CCM2 proteins have been shown to interact in vitro [Zawistowski, 2005] 
suggesting they form a molecular complex that probably involves MAPK and the 
p38 pathway. Whether CCM3 has a similar interaction remains to be seen. Recent in 
vivo studies on murine and zebrafish models when CCM1 and CCM2 were 
inactivated shed some light on their roles in cardiovascular development. Although 
both model embryos died at midgestation, before cerebral blood vessels had 
developed, it was clear that they are involved in arterial morphogenesis and 
differentiation during early embryonic life. If and when conditional mutants in which 
CCM genes specific to the central nervous system (CNS) are inactivated that can 
survive to full term are developed it will give exciting insight to the pathogenesis of 
cavernomas. 
 




The identification of three CCM genes is an important step towards understanding 
the mechanisms of the disorder. These genes have helped clarify certain features of 
the disorder such as the incomplete clinical and neuroradiological penetrance of the 
familial form, as well as the molecular basis of ‘sporadic’ cases with multiple 
lesions. It will be down now to additional large series studies, like SIVMS, to further 
assess genotype-phenotype correlations, particularily prognosis in relation to the 
nature of the mutated gene. It is likely that there are, as yet, other unidentified genes 
in familial cases in whom no gene has been identified, or it is possible that sporadic 
single cases harbour a genetic defect as yet undeclared. Another possibility is that 
there may be a modifying gene explaining intrafamilial clinical variability. 
 
Identification of CCM genes also means that molecular genetic screening is now 
possible. When screening all three genes in a CCM proband, sensitivity of genetic 
screening is 96% in patients with an affected relative, and 57% in sporadic cases with 
multiple lesions [Labauge, 2007]. However, once the mutation has been identified 
within a proband, sensitivity is 100% when screening relatives of the patient. This 
raises all sorts of questions about how molecular genetics screening affects clinical 
care of patients and their relatives. What are the indications for genetic and magnetic 
resonance imaging (MRI) screening in asymptomatic individuals? Is screening 
justified at all when there is no reliable evidence what the best management is for 
asymptomatic, or indeed symptomatic patients? Are patients better off not knowing? 
There are very real parallels between this situation and the hotly debated topic of 
screening relatives of patients with aneurysmal subarachnoid haemorrhage [Miller, 




2011]. Genetic screening should always be on a background of balanced risk-benefit 
ratio. This will not be an issue easily resolved and will lead to many earnestly argued 
debates in the future.  
Truly sporadic cases of cavernomas are thought to harbour mostly single lesions, are 
not inherited and do not carry a CCM gene mutation. However, in all case series 
based on cases presenting clinically as sporadics, a significant proportion of the 
cohort have had multiple lesions when examined by gradient echo (GRE) MRI. It 
now appears that a sizeable proportion of this group is actually a result of genetic 
mutations whether undiscovered familial or new mutations. In a study done by 
Labauge et al [Labauge 1998] clinical and neuroradiological analyses done prior to 
the identification of CCM genes in a series of 22 consecutive sporadic cases with 
multiple lesions showed that 75% of them were affected with a hereditary form of 
the disease with incomplete penetrance because one of their two asymptomatic 
parents showed lesions on MRI. These patients were true familial genetic cases. Of 
the remaining 25% whose biological parents had a normal gradient echo MRI some 
were affected by a hereditary form of the disease as they were shown subsequently to 
carry a de novo mutation in one of the three CCM genes [Denier, Labauge et al, 
2004], [Denier, Goutagny et al, 2004] and [Bergametti, 2005]. Whatever the cause, 
the real life implications of this are for the progeny of these people as well as 
themselves in terms of genetic counselling and screening. For researchers like myself 
gathering a cohort of apparently ‘sporadic’ cases it is sobering that, undoubtedly, a 
significant proportion of our multiple cases will have a heritable form of the disease 




and hence have consequences for their children and also, potentially, for their 
extended asymptomatic family. 
 
1.2.2  Radiotherapy cavernomas 
It was as recent as 1994 when it was first mooted [Gaensler, 1994] that intracranial 
cavernomas develop post radiotherapy. The effect is largely evident in children 
[Nimjee, 2006] although the much more rare de novo formation post radiotherapy in 
adults is also documented [Alexander, 1998] and [Furuse, 2005]. The three most 
common primary lesions requiring radiotherapy and subsequently leading to 
cavernoma development are medulloblastoma, glioma and acute lymphoblastic 
leukaemia in decreasing order of frequency [Nimjee, 2006]. There are wide ranges of 
latency periods published in case reports but bigger case series estimate a mean 
latency period of 8.9years [Nimjee, 2006] to a median latency period of 10.5years 
[Heckl, 2002] post radiotherapy treatment. What is clear from Heckl’s study is that 
the length of latency is directly related to the dose of radiation given [Heckl, 2002]. 
What is also clear from the literature is that cavernomas develop inside the radiation 
field and also the radiation port regions.  
 
Why intracranial radiation should result in cavernoma formation is still unclear, as is 
the aetiology of sporadic intracranial cavernoma formation. One theory, however, 
supposes the involvement of vascular endothelial growth factor (vEGF) as a possible 
mechanism post radiotherapy inducing angiogenesis [Tsao, 1999]. This would tie in 




with the potential mechanisms emerging in the literature about pathogenesis of 
familial and sporadic cavernomas i.e. abnormal angiogenesis. However, these are all 
theoretical at the moment and are some way from a cogent explanation of cavernoma 
pathogenesis. However, the reality is that cavernomas form in some people, 
particularly children, post radiotherapy to the brain and also spinal cord. 
 
1.3 Radiological diagnosis of intracranial cavernous malformations 
Cavernomas are low flow collections of vascular channels lined by endothelium and 
collagen but without any intervening brain parenchyma. As discussed previously 
(section 1.1.1) there is also an absence of the elastic and smooth muscle components 
of the ‘normal’ vessel walls. The caverns or vascular channels contain blood at 
various stages of stasis, thrombosis, organisation and calcification. Initially they were 
diagnosed on post mortem and thought to be vanishingly rare. Subsequently with the 
advent of cerebral angiography (1927) their existence was implied by displacement 
of the normal angioarchitecture but they were not directly visualised due to their low 
flow. They were conspicuous by their absence and hence the umbrella term 
‘angiographically occult vascular malformations’. Again the frequency with which 
they were diagnosed was so low that their clinical significance in population terms 
was often doubted. Nor are they easily identified on CT imaging unless they are large 
and contain a substantial amount of calcification. Therefore, until the advent of MR 
imaging they remained largely under the clinical radar.  
 




In the mid 1980’s when MR was introduced into clinical use, clinicians began to 
realise the significance of cavernomas in terms of morbidity among patients and also, 
occasionally, mortality. Since then much has been published about the usefulness of 
imaging in the diagnosis of cavernomas, in particular asymptomatic lesions. 
  
Pathology remains the established gold standard for diagnosis of intracranial 
cavernomas but, with the evolution of MR scanners and techniques, MR is fast 
assuming the upper hand in the diagnostic algorithm for cavernomas. It has distinct 
advantages over pathology in that it is non-invasive, can be done repeatedly in life 
and can be used without any harmful side effects. Therefore, it is crucial to get the 
imaging and pathological correlation right. In this section I will discuss the role 
imaging plays, firstly, in establishing the diagnosis and, secondly, in expanding the 
knowledge base about the aetiology and development of cavernomas.   
 
1.3.1 Cerebral angiography 
Cerebral angiography is a technique where catheter access to the cerebral arterial 
system is gained by direct puncture of, usually, the femoral artery. There is 
synchronous contrast injection directly into the arterial system with real time 
screening to observe the outlined cerebral vasculature. While the technique is a lot 
more refined today than when it was originally developed in Portugal in 1927 by 
Moniz, the principle is much the same. Prior to non-invasive imaging of the brain 
cerebral angiography was the only way of indirectly imaging intracranial 




cavernomas. The clues to their presence were a paucity or displacement of the 
normal angioarchitecture of the brain on early arterial phase imaging without 
abnormal arterial feeding vessels, or displacement of vessels by mass effect from 
haemorrhage outside the cavernoma. On slightly delayed phase screening a subtle 
vascular blush is sometimes evident and in the venous phase a few large draining 
veins may be seen [Bartlett, 1977] & [Numaguchi, 1977]. The technique of 
prolonged injection of contrast helps delineate intracranial cavernomas [Rosenbaum, 
1969].  Although angiography suggested the possible presence of intracranial 
cavernomas, it was by no means specific in the diagnosis of these’angiographically 
occult vascular malformations’ [Hallam, 1998] and it was not until the advent of 
computed tomography (CT) and MR in the 70’s and 80’s respectively that imaging 
could begin to rival pathology as the ‘gold standard’ for diagnosis of intracranial 
cavernomas.  
 
1.3.2 Computed Tomography (CT) imaging 
By the mid 1970’s and early 1980’s there was a body of evidence amassing that 
highlighted the usefulness of CT in combination with angiography in detecting 
intracranial cavernomas and sometimes in distinguishing them from the other 
subtypes of angiographically occult or low flow vascular malformations [Bartlett, 
1977] and [Maehara, 1981]. The CT features are described as “round or oval 
hyperdense lesions without significant mass effect and with normal surrounding 
brain tissue in the majority of cases” [Sage, 1993]. They may also appear calcified 




and occasionally have a post contrast blush. Again, although these features suggest 
the diagnosis, they are not specific for cavernomas but indicative often of the more 
general category of ‘low flow’ lesions (cavernomas, partially thrombosed AVMs, 
venous angiomas and capillary telangiectases) [Rapacki, 1990] or granulomas, 
oligodendrogliomas, astrocytomas and thrombosed AVMs. 
 
1.3.3 Magentic Resonance (MR) imaging 
By the mid to late 1980’s studies were being published comparing CT imaging and 
angiography to the utility of the newly introduced MR imaging in the diagnosis of 
pathologically verified cavernomas [Rigamonti, 1987] and [Harder, 1989]. It quickly 
became clear that MR was far superior in its sensitivity and also specificity although 
this was not rigorously quantified until our study, the details of which come later in 
the thesis (Chapter 8).  
 
An illustration of the new clinical significance of MR in the correct diagnosis of 
intracranial cavernomas was highlighted by Preul et al [Preul, 1992]. 11 cases of 
brainstem cavernomas were misdiagnosed on CT and angiography as brainstem 
tumours. Patients had undergone a variety of treatments such as external radiation, 
ventriculo-peritoneal shunting, corticosteroid treatment and brainstem biopsy leading 
to a diagnosis of glioma. Subsequent MR scans depicted the characteristic 
appearance of intracranial cavernomas and 6 patients eventually underwent 
sterotactic radiosurgery.  




A whole plethora of studies from the mid 1980’s and 1990’s have catalogued the 
superior utility of MR over CT [Vielvoye, 1992], [Biondi, 1986] and also the typical 
appearances of cavernomas on MR imaging [Barker, 1993], [Bien, 1986]. In 1994 
however, Zabramski et al published the seminal study describing a classification 
system for intracranial cavernomas based on their MR signal characteristics and also 
their pathological characteristics [Zabramski, 1994]. This classification depicted in 
Table 1 is now in widespread use and has not yet been superseded by any other 
classification system in clinical practice. 
Table 1 Zabramski classification 
Lesion 
type 




: hyperintense core 
T2
2
: hyper- or hypointense core with surrounding hypointense rim 
Type 2 T1: reticulated mixed signal core 
T2: reticulated mixed signal core with surrounding hypointense rim 
Type 3  T1: iso- or hypointense 




: hypointense with greater magnification than T2 
Type 4 T1: poorly seen or not visualized at all 
T2: poorly seen or not visualized at all 
GE: punctate hypointense lesions 
                                                 
1
 T1 weighted sequence on standard spin echo MRI 
2
 T2 weighted sequence on standard spin echo MRI 
3
 Gradient echo sequence 




Magnetic resonance imaging is developing year on year. As technology and our 
understanding of how it can translate into clinical use advances, the degree of 
sensitivity and specificity of MR in the diagnosis of cavernomas also improves. 
Fundamental to this is the understanding at a molecular level of the behaviour of 
different forms of iron within the brain such as ferritin and haemosiderin when 
placed within the magnetic field of an MR scanner [Vymazal, 2000] and thus as a 
consequence the characteristics intrinsic to cavernomas that specifically determine 
their appearance on different MR sequences.  
Nearly twenty years after Zabramski defined the radiological subtypes of 
cavernomas, the increasing sophistication of MR imaging combined with our 
evolving understanding of the pathological basis underpinning what we see on 
images allows us to question the validity of Type 4 cavernomas as described by 
Zabramski. These punctate hypointense lesions seen only on GE MR sequences or 
SWI are made visible by the paramagnetic properties of blood products or 
calcification both of which are indeed associated with cavernomas but importantly 
this is identical to the appearance of microbleeds seen in conditions such as 
hypertensive encephalopathy and cerebral amyloid angiopathy. Clearly this category 
of cavernoma has overlap with other pathologies and must not be over relied upon. 
 
1.3.3.1 T1 & T2 spin-echo and Fast spin-echo sequences 
The early studies of MR were based on simple T1 & T2 weighted spin echo 
sequences [Barker, 1993], [Biondi, 1986], [Bien, 1986]. These allow depiction of the 




characteristic appearances of Zabramski Type 1, 11 and 111 lesions (table 1) 
[Zabramski, 1994]. However type 4 lesions are usually not seen at all by using these 
sequences alone. T1 & T2 spin-echo are also still the mainstay of most general brain 
imaging protocols and are often the first sequences done even in the setting of 
cerebral haemorrhage or suspected vascular malformations. 
 
1.3.3.2 T2*, T1 & T2 gradient echo sequences 
These sequences focus particularly on accentuating the susceptibility effects of 
paramagnetic substances like haemosiderin, thus increasing the prominence of the 
rim of signal loss which characteristically surrounds type 1 to 3 cavernomas ( this 
feature is more commonly known as ‘blooming artefact’). To be visualised at all, 
type 4 lesions rely on this blooming artefact and are therefore exclusively 
demonstrated on gradient echo sequences. Many small series have been published 
about the superiority of these sequences in diagnostic algorithms for intracranial 
cavernomas [Siebner, 1999], [Brunereau, 2000] & [Duchene, 2002]. Through these, 
albeit small studies, it has become clear that T2* gradient echo wins out in terms of 
maximising sensitivity and specificity of MR in the diagnosis of intracranial 
cavernomas. Once a cavernoma is suspected it now forms part of the MR protocol 
for diagnosis of intracranial cavernomas in most neuroscience centres. Because of 
time pressures on MR scanners in most NHS regions, however, gradient echo is still 
not a sequence used for routine screening of the brain. 
 




1.3.3.3 Susceptibility weighted imaging (SWI) 
This is an emerging high-resolution 3D-gradient echo sequence that creates an image 
based on T2*-contrast and the phase changes due to magnetic susceptibility. The 
magnetic susceptibility of deoxygenated blood, haemosiderin, methaemoglobin or 
ferritin produce a strong hypointense signal in the processed susceptibility weighted 
images and therefore allows high resolution depiction of venous structures, blood 
products and iron deposits. The technology has been available in clinical practice 
since 1997 [Reichenbach, 1997] but is rarely part of the routine imaging protocols 
for brain cavernomas. This is likely due to the prolonged acquisition times when 
using a 1.5tesla MR scanner. With higher field strength scanners (3 tesla and above) 
come improved conditions for SWI and as these scanners become more widespread 
in clinical practice, so too will the use of SWI. The major advantages of SWI is its 
superiority in detecting a greater number and smaller cavernomas as reported in 
several studies in the last 10 years [Rauscher, 2005],[Sehgal, 2005],  [Lee, 1999], 
[Pinker, 2007] and [de Souza, 2008]. Also, several studies have reported the 
excellent depiction of developmental venous anomalies on non-contrast enhanced 
susceptibility weighted imaging over conventional MR imaging [Fushimi, 2008], 
[Lee, 1999], [Mittal, 2009] and [Tsui, 2009]. No published studies however report on 
the use of SWI in cavernoma cases associated with developmental venous anomalies 
although it is likely that its superiority will be demonstrated here also. This would 
have specific benefits in terms of pre-operative planning.  
 




The major drawback of SWI is the prolonged acquisition time. However this can 
now be compensated for with higher field strength scanners. Once these are in 
widespread use in the clinical setting, this issue should cease to be a limiting factor.  
Signal dropout and phase artefacts, particularily at air-tissue interfaces, can impinge 
on the detection of cavernomas in particular areas such as the rostral skull base and 
the temporal lobe adjacent to the petrous bone. Another problem particularly relevant 
for size measurement and surgical planning is the more marked ‘blooming’ of 
strongly paramagnetic blood products, particularily at higher field strengths, thus 
artificially increasing lesion size. There are some technical ways of limiting the 
impact of this problem but details of this are beyond the scope of this thesis. 
 
1.3.3.4 Diffusion tensor imaging (DTI) and tractography 
This is a new potentially exciting adjunct to MR imaging that may give new insights 
into the effects of cavernomas on the adjacent white matter and how the 
haemosiderin and white matter affected by it survive their intimate relationship. 
Diffusion tensor (DT) imaging aids visualisation of the directionality and orientation 
of the white matter tracts of the brain. Recent studies have used DT tractography to 
characterise the haemosiderin rim surrounding the cavernoma and also as an aid in 
surgical planning for the resection of cavernomas in eloquent areas. Cauley et al 
[Cauley, 2010] performed tractography in 18 patients with solitary cavernomas and 
concluded that the central core of cavernomas deviate white matter tracts around 
them , with tracts often passing through the haemosiderin rim on their way. Data 




from this study also supported the idea that the haemosiderin rim is, at least in part, 
made up of viable tissue and is intimately associated with white matter tracts 
deviated around the central lesion. Chen et al reported that DT fibre tracking 
revealed the anatomical relationship between local eloquent tracts and the 
cavernoma, which altered their surgical approach to the brainstem and helped 
prevent patient morbidity[Chen, 2007] and [Chen, 2007] . Niizuma et al [Niizuma, 
2006] report the successful use of fiber tracking to locate the displaced corticospinal 
tract for the removal of a paraventricular cavernoma. Therefore it appears that the 
future of DT imaging lies as a tool within the surgical planning process and also as 
an aid in deepening our understanding of the relationship between lesion location, 
size and clinical symptoms. 
 
1.4 Role of MR imaging in establishing the natural history of cavernomas.  
Moving on from my discussion on the role of imaging in the diagnosis of 
cavernomas, imaging has also played a significant role in dispelling the myth that 
cavernomas are congenital lesions. The spontaneous formation of de novo 
cavernomas in both the familial and sporadic forms is now well documented using 
MR imaging. 
 
 In 1994, Zabramski et al [Zabramski, 1994] performed serial MR scans on patients 
with familial cavernomas and documented the formation of six new lesions in 21 
patients during an average follow-up period of 2.2 years.  Similarly in 2000 




Brunereau et al [Brunereau, 2000] retrospectively reviewed serial MR scans on 
patients with the familial form of the disease and again confirmed the formation of 
de novo lesions at a quoted rate of 0.2 lesions/patient-year with an average follow-up 
of 3.2 years. Similar de novo development has also been documented in the sporadic 
form of the disease [Pozzati, 1989] and [Detwiler, 1997]. In my cohort at least one 
patient’s sequential MR imaging identified development of a second cavernoma 
during the period of observation. The clear formation of new lesions, along with the 
knowledge that the KRIT 1 protein acts as a tumour-suppressor gene, makes a case 
for the reclassification of cavernomas as benign vascular tumours, similar to 
haemangiomas, rather than congenital lesions. This has implications for the 
calculation of bleeding risks as it can no longer be assumed that the  at risk period is 
from birth. Serial MR also demonstrates that cavernomas, whether familial or 
sporadic, are not static lesions. Their size can increase over time without direct 
evidence of haemorrhage [Zabramski, 1994], [Pozzati, 1989] and [Pozzati, 1996].  
 
Finally, serial MR imaging has also allowed the connection between radiotherapy 
and subsequent development of cavernomas to be made [Nimjee, 2006], [Pozzati,  
1996] and [Larson, 1998]. This de novo formation post radiotherapy treatment has a 
latent period of 3 to 10 years. These new insights into cavernoma development and 
behaviour captured by MR imaging add to the evolving body of evidence regarding 
their aetiology and natural history. 
 




1.5 In summary 
 Approximately 110,000 people are diagnosed each year in England with 
stroke. 
 Intracranial cavernous malformations are a rare cause of stroke, most 
significant in young people. 
 Histopathology is the Gold standard for diagnosis but MR imaging is now 
accepted as a close second which is more clinically useful. 
 A proportion of cavernomas coexist with developmental venous anomalies. 
 Intracranial CMs can be familial, sporadic or secondary to radiotherapy. 
 The conventional wisdom that CMs were present from birth is now known to 
be false. They appear de novo at various points throughout life. 
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2.1 Introduction 
The ambition of this thesis is to improve the accuracy and power of aspects of 
intracranial cavernous malformation epidemiology already published [Al-Shahi, 
2003] and then to present new high quality data about their natural history, in 
particular presentation and prognosis.  
 
The natural history of any disease is composed of certain stages which are 
graphically illustrated below: 
 
Figure 4 Graphic illustration of the stages of natural history of a disease 
[Sackett's Clinical Epidemiology, 1991] 
 








In the context of intracranial cavernous malformations, biologic onset is unknown, 
except to say they are not present at birth. The usual clinical diagnosis is made when 
a patient presents with symptoms. But, now that MR imaging is widely available, 
early asymptomatic diagnosis is becoming increasingly more common. It is really 
Time 
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from this point that the story of cavernoma natural history begins in practice and so 
too in this thesis. 
 
2.2 Specific aims of thesis 
 
2.2.1 Incidence of intracranial cavernous malformations in SIVMS 
Incidence is a measure of the risk of developing a new condition within a specified 
period of time. A preliminary review of the literature on cavernomas clearly 
indicated a dearth of studies that meet the criteria for the proper measurement of 
incidence. The setting up of the first prospective, population-based study, SIVMS 
(The Scottish Intracranial Vascular Malformation Study), in 1998 provided the 
patients to answer this key question. 
 
2.2.2 Presentation and early prognosis of intracranial cavernous malformations 
in SIVMS 
In terms of natural history, the logical step after estimation of disease incidence in a 
population-based cohort is to establish the modes of presentation and prognosis of 
the disease. Intracranial cavernomas are well documented as causes of haemorrhage, 
epilepsy, focal neurological deficits and many more neurological symptoms. What is 
not clear however, is the relative proportions with which these symptoms occur, and 
also how many cavernomas are asymptomatic at presentation? This information is 
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fundamental to understanding the condition and eventually uncovering patients’ true 
prognosis. SIVMS recorded modes of presentation and prognosis for a five year 
period (from January 1999 to December 2003) in an inception cohort, and as a 
prospective study of the Scottish population aged over sixteen years, is ideally 
designed to do this.  
 
2.2.3 Treatment of intracranial cavernous malformations in SIVMS 
The treatments available for cavernomas are complete or partial surgical excision, 
radiosurgery (Linear accelerator (LINAC) or Gamma-knife) or medical management 
of symptoms.  Appropriate evaluation of treatments would ideally be in the form of a 
randomized controlled trial. For many reasons this is not currently feasible and 
unlikely to happen for many years to come. SIVMS is an observational study. All 
management decisions were taken remote to SIVMS and were between the clinician 
and patient. As a result, and compounded by the small numbers involved, I will 
merely describe the numbers that were treated and how they were treated, but 
drawing conclusions from these data would be ill advised and will not be done.  
 
2.2.4 Validity of MR imaging in the diagnosis of cavernomas 
As discussed already in Chapter 1 MR imaging has evolved as the most clinically 
appropriate diagnostic tool for intracranial cavernomas. It is also widely accepted to 
be the new ‘Gold standard’ in diagnosis and is even used in practice as a screening 
tool for relatives of patients with the familial form of the disease. However this 
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wisdom has never been objectively challenged in the literature and we set out to do 
this with a study designed to quantify the sensitivity and specificity of MR imaging 
in this setting. Validating the use of MR as a diagnostic tool for cavernomas was 
even more important for us as the criteria for inclusion in SIVMS were based on a 
definite diagnosis on MR imaging or histopathology. In practice, the vast majority of 
patients in SIVMS met the criteria for inclusion based solely on imaging. 
 
2.3 Thesis structure 
This thesis is structured as follows; the introduction, aims and outline are followed 
by a systematic review of the published literature on the natural history of 
intracranial cavernous malformations in adults. This will then be followed by a series 
of chapters focussing on the methods and results in SIVMS, a separate chapter for 
each of these topics; incidence, presentation, early prognosis and treatment. After 
this a separate chapter focussing on the validity of MR imaging in the diagnosis of 
cavernomas will round off results. The thesis will finally draw to a close with a 
conclusion and discussion about the future of research on brain cavernomas. 
 
2.4 In summary 
In summary, my aim was to establish the epidemiology and natural history of 
intracranial cavernomas in adults and also to quantify the suitability of MR imaging 
in their diagnosis. SIVMS was an excellent vehicle to do this. 
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Chapter 3:  
A systematic review of the literature on intracranial 
cavernous malformations 
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3.1 Introduction 
Embarking on a study and a thesis of this nature it is essential to familiarize oneself 
with the available literature relevant to the subject. Therefore I did an electronic 
search of the literature deliberately casting a wide net in my search strategy to err on 
the side of being over inclusive rather than under inclusive. My search strategy was 
devised with the help of Brenda Thomas, the Trials Search Co-ordinator of the 
Cochrane Stroke Group Editorial Team and my thanks go to her. The strategy was 
also reviewed by Dr Al-Shahi who at this point had amassed experience in 
exhaustive electronic searching of the literature. 
 
The results of this search were the basis for the literature review in this chapter. It 
was last updated in April 2011 when my thesis began taking form. 
    
3.2 Methods 
The 20 line search strategy devised (see tables 2 & 3) was used to electronically 
search the Ovid MEDLINE and EMBASE databases. My search was not limited by 
language, patient’s age or study type. As such any paper whether case report or 
randomized controlled trial was retrieved. MEDLINE was searched from 1966 to 
April 2011 and EMBASE from 1980 to April 2011. They yielded respectively 2137 
and 3167 references which were imported into reference manager software version 
10.0. A duplicate search was performed and any duplicates were deleted. 3038 
references remained. The titles and abstracts of all references were reviewed and 
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coded with personalised keywords such as 'incidence, prognosis, presentation etc'. 
For the review of studies of incidence, for example, all abstracts coded as such were 
retrieved and the full articles of all except case reports reviewed. The electronic 
search was supplemented by a hand search of the bibliographies of pertinent articles. 
This process was followed for studies of presentation, prognosis and treatment. 
I separately searched for completed and ongoing clinical trials with any connection 
to cerebral cavernous malformations. This search encompassed The Cochrane  
Library including the Cochrane Stroke Group’s specialised register of trials 
(http://www.thecochranelibrary.com/ and http://stroke.cochrane.org/) and also the 
US National Institute of Health’s’ clinical trials registers (http://clinicaltrials.gov/ 
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1 Exp Cerebral arteries/ 
2 expCerebral arterial diseases 
3 Exp Cerebral veins/ 
4 (cerebral or cerebell$ or brain$ or supratentorial or infratentorial or 
parenchymal).tw. 5 Exp Hemangioma, cavernous/ 
6 Cavernous haemangioma$.tw 
7 Cavernoma$.tw. 
8 Cavernous angioma$.tw 
9 (cavernous adj5 malformation$).tw 
10 Exp Intracranial arteriovenous malformations/ 
11 Exp cerebral haemorrhage/ 
12 Exp epilepsy/ 
13 Exp cerebral angiography/ 
14 Exp brain neoplasma/ or exp infratentorial neoplasms/ or exp 
supratentorial neoplasms/ 15 1 or 2 or 3 or 4 
16 5 or 6 or 7 or 8 or 9 
17 10 or 11 or 12 or 13 or 14 
18 15 and 16 
19 5 and 17 
20 Exp Hemangioma, cavernous, central nervous system/ 




The nature, frequency and natural history of intracranial cavernous malformations in adults 
 
A systematic review of the literature on intracranial cavernous malformations 39 
 
Table 3 Electronic literature search strategy; Embase from 1980 to April 2011  
Set Search 
1 Exp brain artery/ 
2 Exp brain vein/ 
3 (cerebral or cerebell$ or brain$ or supratentorial or infratentorial or 
parenchymal).tw. 
4 Exp Cavernous Hemangioma/ 
5 Cavernous haemangioma$.tw 
6 Cavernoma$.tw. 
7 Cavernous angioma$.tw 
8 (cavernous adj5 malformation$).tw 
9 Exp Brain arteriovenous malformation/ 
10 Exp Brain haemorrhage/ 
11 Exp epilepsy/ 
12 Exp brain angiography/ 
13 Exp brain hemangioma/ or exp brain stem tumour/ or exp brain tumour/ or exp 
cerebellum tumour/ or exp intracranial tumour/ 
14 1 or 2 or 3 
15 4 or 5 or 6 or 7 or 8 
16 9 or 10 or 11 or 12 or13 
17 14 and 15 
18 4 and 16 
19 17 or 18 
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3.3 Incidence / Measurement of disease occurrence 
Measurement of disease occurrence (incidence/prevalence) is fundamental to the 
science of disease epidemiology. Although the concept is simple the practical 
application of theoretical incidence measurement is complex. Virtually all studies of 
incidence have inherent weaknesses and execution of the perfect study of disease 
incidence is almost impossible in today’s world with regard to financial and ethical 
constraints – not that I am denouncing these constraints, I am simply highlighting the 
implications that they have for clinical research. 
 
Estimation of disease incidence, or indeed prevalence, is essential for two main 
reasons. Firstly, it is the cornerstone of health service planning and allows health 
service delivery organisations to ‘prioritise for action’ and secondly, but by no means 
least, it is the inaugural step in establishing the natural history of any disease process. 
I will now discuss the definition of incidence and the methodological criteria that are 
desirable in a study of incidence. 
 
Incidence is loosely defined as the counting of new cases in a defined population at 
risk. More commonly there is a dimension of time added to it and consequently the 
conversion of absolute numbers into a ‘rate’ has much more use, as was 
demonstrated by Snow in the London cholera epidemic in 1855. There are two main 
ways of calculating incidence rate. Firstly, true ‘incidence rate’ is what Last calls 
“person-time incidence rate”[Last, 2001]. Each person in the study population 
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contributes one person year to the denominator for each year of observation before 
disease develops or that person is lost to follow-up. The numerator refers strictly to 
first events of disease. The units of rate always include a dimension of time.  
 
The second, and probably the one most relevant to this clinical setting, is the 
cumulative incidence rate or crude incidence. It is a simpler measure of the 
occurrence of disease. Unlike incidence rate, it measures the denominator only at the 
beginning of the study. The denominator is therefore the number of people free of the 
disease in the population at risk at the beginning of the study. It is often presented as 
the rate per 100,000 population per year. 
 
Germane to the practice of disease quantification in a population is the ability to 
diagnose the disease in question definitively. In the specific setting of this thesis 
diagnosis of intracranial cavernomas is well established on histopathological grounds 
and now also on imaging since the advent of MR scanners [Zabramski, 1994] as 
discussed in Chapter 1. Either mode of diagnosis would be appropriate for use in a 
clinical research setting but the non-invasive imaging method has many obvious 
advantages.  
 
As intracranial cavernomas can and do arise sporadically in the general population, a 
study population must therefore include the entire population or a representative 
sample. Hospital or single centre based studies are suboptimal because of the many 
The nature, frequency and natural history of intracranial cavernous malformations in adults 
 
A systematic review of the literature on intracranial cavernous malformations 42 
 
selection biases to which they are subject. In general they ignore cases that are either 
too mild or too severe (e.g. sudden death) to require hospitalisation. 
 
To minimise the many biases and confounding factors to which observational 
research is vulnerable, data and case collection should be prospective. Retrospective 
data collection is unreliable and specifically subject to reporting bias and, therefore, 
should generally be avoided. 
 
As previously discussed it is well documented that intracranial cavernomas can 
develop at any point in life (section 1.2.1) i.e. they are not congenital lesions. The 
specific point in time at which they develop (biologic onset) is all but impossible to 
determine as many will be asymptomatic for an indefinite period. Diagnosis of 
asymptomatic cases is serendipitous unless an entire population was screened with 
MR imaging at regular intervals. This would be an impossible task for many reasons 
and therefore many studies make attempts within their methodological limitations to 
estimate the occurrence of asymptomatic cavernomas. With this in mind complete 
case ascertainment is the unattainable goal of any study of cavernoma incidence but 
some studies get closer than others to estimating it correctly. 
 
3.3.2 Incidence of cavernomas in the literature 
Once I applied the desired criteria for a study of incidence [Sudlow, 1996] (table 4) 
to the non-case report studies retrieved in the literature search I soon realized that no 
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study met more than two out of four criteria and all had serious methodological flaws 
(table 5). Therefore, for the purposes of this review I arbitrarily decided to analyze 
all large studies in terms of their usefulness and problems (number of cases (n) = 206 
was the smallest study included). 
 
Table 4 Desired criteria for studies of incidence 
 Definite diagnosis, using standard and explicit criteria 
 Population based 
 Prospective 
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Berry, 1966 ○ ○ ○ ● ● 
McCormick, 
1966 
○ ● ○ ● ● 
Jellinger, 1986 ○ ○ ○ ● ● 




○ ○ ○ ● ● 
Robinson, 1991 ○ ○ ○ ● ● 
Katzman, 1999 ○ ○ ○ ● ● 
Weber, 2005 ○ ○ ○ ● ● 
Vernooij, 2007 ○ ● ○ ● ● 
Hartwigsen,2010 ○ ● ○ ● ○ 
Population based series 
Brown, 1996 ● ○ ○ ● ● 
Mathieson, 2003 ● ○ ○ ● ● 
*N = number of cases 
 
There was only one truly population-based study of incidence [Brown, 1996] in the 
literature (Table 5). It is based on the Rochester Epidemiology Project Medical 
Records Linkage System. This study was not issue free however. It was retrospective 
thus making it susceptible to reporting bias. Diagnostic techniques were primitive 
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during this study period (1965 – 1992) and interestingly no cavernomas were 
diagnosed prior to 1985, when MR imaging was first introduced. This suggests that 
many asymptomatic and symptomatic cavernomas went undetected as diagnostic 
techniques were not sufficiently refined to pick up the diagnosis when a cavernoma 
was present. Also, as MR imaging was not available, the main mode of diagnosis 
was on autopsy and, as cavernomas are less likely than AVMs to cause fatal 
haemorrhage, the chances of picking them up on post mortem alone is slim – one 
cavernoma was found with this method in Brown’s study spanning 27 years. The age 
and sex adjusted detection rates for all cavernomas were estimated to be somewhere 
between 0.17 and 0.5 per 100, 000 per year. 
 
There was a second study that claimed to be population based [Mathieson, 2003] 
(Table 5). This was a Swedish single centre study based at a neurosurgical centre. 
The claim was that, in Sweden, the medical records system is such that any patients 
from their population, but seen in another area, would have been notified to them and 
hence this allowed collection of all cases that come to light clinically. Based on this 
fact their retrospective estimation of symptomatic case incidence was 0.32 persons 
per 100,000 per year. All their asymptomatic cases were from imaging done on 
people who presented with unrelated head trauma, incidental spinal disease or studies 
done on controls from research studies. None were from autopsies. This makes their 
estimation of asymptomatic incidence at 0.08 persons per 100,000 per year likely to 
be an underestimate.  
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The remainder of the large studies of frequency can be divided into two groups based 
on the source of cases – autopsy or MR imaging series. The autopsy series [Berry, 
1966], [McCormick, 1966], [Jellinger, 1986] and [Otten, 1989] were predominantly 
single centre, retrospective studies reporting incidences, or more correctly 
prevalences, ranging from 0.02 to 0.53%. The cohorts were subject to much selection 
bias, reporting and recall bias. Thus it was likely that the very mild and also very 
severe cases such as sudden deaths in the community were not included as they never 
present to hospitals. Autopsy rates will also vary significantly from region to region 
depending on local policies. The studies were quite different in their settings and, 
therefore, comparison of populations between studies is quite hopeless. 
 
Similarly, the studies of MR imaging series [Del Curling, 1991], [Robinson, 1991], 
[Katzman, 1999], [Weber, 2006], [Vernooij, 2007] and [Hartwigsen, 2010] are 
largely plagued by selection bias, reporting and recall bias although the most recent 
studies are getting closer to approximating the incidence of asymptomatic/incidental 
cavernomas. Their case incidences ranged from 0.12 to 0.9%, a wide range reflecting 
the varied study designs, access to and use of MR facilities in different geographic 
locations. The study by Vernooij in 2007 was embedded within the Rotterdam 
Prospective Population based Study and there was MR screening of eligible 
participants all aged >45yrs using a standardized protocol. This study is the one most 
likely to approximate to an ideal study of incidence although it excludes those under 
the age of 45yrs, and in any event, it is in fact a study of prevalence rather than 
incidence. The rates quoted in the study were a combination of prevalent cases with 
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an existing cavernoma at the beginning of the study and incident cases who 
developed  a cavernoma during the study. The true split between these two groups in 
the cohort is impossible to know as diagnosis was only made if the lesion was 
present on MR imaging on one occasion. Therefore this was actually a study of 
period prevalence i.e. those cases that were present on imaging during the duration of 
the study. If all patients had been scanned on a particular day , for instance at the end 
of the study, then this would have represented a point prevalence.  
 
In the MR imaging series studies were again subject to selection bias in being 
hospital/single centre based. Whole swathes of the population were excluded from 
the studies and the cohorts were over selected. 
 
In conclusion, the literature published on incidence/prevalence of intracranial 
cavernous malformations is of poor methodological quality and/or hampered by 
limited tools of diagnosis when the studies were performed prior to the widespread 
availability of MR imaging. 
 
Mindful of these complex issues SIVMS was designed as a practical, if imperfect 
solution to the dearth of information available on the incidence and natural history of 
intracranial cavernous malformations in adults. For reasons I will discuss later in the 
thesis SIVMS is a study that stands methodologically apart from any in the literature 
to date.   
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3.4 Presentation of intracranial cavernomas in the literature 
How cavernomas present is important to consider, especially as our understanding of 
this has changed over the years. The symptomatic presentation of cavernomas has 
been clinically subdivided in the literature into four categories: 
 Haemorrhage 
 Focal neurological deficit 
 Seizures 
 Headache 
The occurrence of asymptomatic cavernomas was thought to be rather small prior to 
MR imaging but what has become clear over the past twenty years is that the size of 
this group is growing fast with a reported prevalence in one study of 0.4% [Del 
Curling, 1991]. As you will see later in this thesis, this group is now the largest 
subtype of presentation in our population-based study, SIVMS. This raises all sorts 
of important questions about the significance of ‘incidental’ cavernomas. This, 
however, is a discussion not confined to cavernous malformations. Today there are 
many ‘incidental’ findings on MR imaging as the systematic review by Morris et al 
highlighted in the BMJ in 2009 [Morris, 2009]. This is fast becoming a real 
conundrum for clinicians. How significant are they? Who should we tell? What 
treatments can we offer? The answers are not clear. 
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As a relatively poorly studied subgroup, this asymptomatic group have the potential 
to alter significantly our understanding of natural history to date. This possibility was 
clear early on in my review of the literature. 
 
The literature published in peer reviewed journals touching on the subject of natural 
history or presentation of sporadic intracranial cavernous malformations consisted of 
data collected in all instances from a single centre, most commonly a surgical centre.  
There was no population-based data on the proportions of the subtypes of cavernoma 
presentation in a population.  
 
All studies agreed on the subdivision of presentation into the five categories of: 
haemorrhage, focal neurological deficit, seizures, headache and 
incidental/asymptomatic. Comparison between cohorts was fruitless as the 
proportion of patients with each presentation subtype varied widely across the 
studies. Among studies with over 100 cases the breakdown of presentation subtype in 
the cohorts varied as shown in table 6 [Del Curling, 1991], [Barker, 2001], [Aiba, 
1995] & [Porter, 1997]. As the cohorts originated mostly from single surgical 
centres, it is likely the variation was due to differences in referral practices between 
regions and countries. For example: sometimes only the most severely afflicted 
patients were referred to the centres for tertiary treatment and this may be the reason 
for a heavy preponderance of haemorrhagic and epilepsy presentations in these 
cohorts. 
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Table 6 Published presentation subtypes 
Presentation subtype Range of published estimates of the 
relative proportion of presentation 
subtypes within cohorts of natural 
history studies with n > 100 
Incidental 0 – 21 % 
Haemorrhage 9 – 100% 
Epilepsy 0 – 50% 
Focal neurological deficit 0 – 22% 
Headache 0 – 34% 
 
The cohort sizes varied enormously, from 13 [Tagle, 1986] to 141 [Barker, 2001] 
which is important to acknowledge. On occasion the cohort numbers in a publication 
were also bolstered by cases (case reports and small case series) already published in 
the literature. This practice serves to add to the description of types of presentation 
but falls far short of adding to our understanding of the burden of different types of 
presentation in a population.  
 
In the literature, the focus on symptomatic cavernomas was to the exclusion of data 
on asymptomatic cases. Just three studies acknowledged inclusion of incidental, or 
more appropriately asymptomatic, cases, the largest being Aiba’a study with 23 
incidentally diagnosed patients [Kupersmith, 2001], [Aiba, 1995] & [Sage, 1993].  
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Data collection was also most commonly retrospective. In fact Kondziolka’s study in 
1995 was the only one to claim some prospective data collection [Kondziolka, 1995]. 
With retrospective selection of cases at surgical centres on the whole, it is difficult to 
imagine how asymptomatic cases could have come to light for inclusion and this is 
perhaps why they have not been on the whole. 
 
Another issue highlighted by my review was the lack of clarity or consensus in the 
literature on the definitions of the different subtypes of presentation, especially 
concerning haemorrhage. This is a theme that also runs through the studies of 
prognosis. An example of the confusion is that some studies were content defining 
haemorrhagic presentation by imaging alone [Kondziolka, 1995] & [Kim, 1997], 
some combined imaging evidence with clinical symptoms [Aiba, 1995] and others 
were content with haemorrhage defined solely as clinical deterioration [Barker, 
2001]. One study failed to document a clear definition of haemorrhage at all [Kim, 
1997]. To cause even more obfuscation there was variation even within the definition 
of imaging evidence of haemorrhage – CT or MRI evidence, haemorrhage within or 
outside the lesion, and a minimum increase in size of the lesion before haemorrhage 
could be confirmed. This issue has been addressed recently in a workshop of the 
Angioma Alliance Scientific Advisory Board and a standardized definition of 
haemorrhage and other major outcomes has now been proposed [Al-Shahi, 2008].  
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Although epilepsy seems to be one of the major modes of presentation, the studies 
included in this review omit a clear definition of this clinical event also. Therefore 
the quantification of ‘epilepsy’ as a mode of presentation, and indeed as an outcome, 
is of limited use clinically. Lack of clarity limits the translation of ‘epilepsy rates’ 
onto other populations and also limits meta-analysis between studies.  Refining 
epilepsy presentation definition, and similarly outcome definition, into categories 
such as; first ever seizure or epilepsy (meaning two or more seizures) but both 
referable to the anatomic location of the CM and not caused by another event such as 
haemorrhage, would be more useful. 
 
As I will discuss later in this thesis, focal neurological deficit (FND), as a clinical 
event related to cavernomas can be defined in various ways. In an ideal world FND 
is symptoms or signs of neurologic dysfunction, referable to the anatomic location of 
the CM, but without evidence of ICH, cerebral infarction, epileptic seizure (Todd’s 
paresis), or migraine. To be precise about this in a research study setting would 
require all patients’ presenting with such symptoms to have prompt neurological 
evaluation combined with appropriate imaging. Unfortunately this is not always the 
case and therefore the overlap in terms of signs and symptoms between haemorrhage 
and FND as clinical events can be difficult to unpick. Studies thus far have failed to 
be explicit about their definitions of FND and therefore it is impossible to estimate 
how much overlap there is in these studies between the FND and haemorrhagic 
presentation groups. 
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Headache will always be a contentious issue. The neurological community continues 
to be divided about whether cavernomas themselves, without overt haemorrhage, can 
cause headache by virtue of their anatomic location.  In studies of presentation, and 
similarly studies of prognosis, I think it is reasonable to include it as a mode of 
presentation or outcome, but going one step further and ascribing a cause to it is less 
easy.   
 
All of these issues play their part in undermining the quality of the available 
published data on the natural history and, more specifically, the frequency of the 
subtypes of presentation of intracranial cavernomas in a population. This was what 
SIVMS sought to address in the prospective, population-based design of the study 
with clear definitions of all clinical events. 
 
3.5 Prognosis in the literature 
 
3.5.1 Introduction 
This particular aspect of the literature review was undertaken by me and Dr Al-
Shahi. I formulated the search strategy as previously described and coded the search 
results accordingly. The inclusion criteria for studies of prognosis detailed in the next 
section were agreed between me and Dr Al-Shahi. Once I had done a preliminary 
sort through the published literature, the potentially relevant articles were read in full 
by both me and him. We independently decided which studies met our criteria for 
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inclusion and if disagreements arose, the final nine included in this review were as a 
result of consensus between us both.  
 
3.5.2 Results 
Once the diagnosis has been made and the patient has ‘presented’ we move into a 
subsection of the natural history called ‘clinical course’. In Sackett et al.’s book of 
Clinical Epidemiology there is a very eloquent description of the desired criteria of a 
study of clinical course/prognosis [Sackett’s Clinical Epidemiology, Chapter 6]. 
With good reason studies of prognosis should have the following criteria: 
 Inception cohort – that is patients included at an early and uniform point 
 Population based 
 Complete follow-up achieved 
 explicit and objective terms used as prognostic outcomes 
 Outcome assessment blinded to any potential prognostic factors 
With the above in mind I reviewed the published literature.  
No study met all of the desired criteria of a study of prognosis. Since various criteria 
were missing from all the studies reviewed I arbitrarily set my inclusion threshold to 
a cohort size of >50 cases and, therefore, distilled the published studies down to 9 of 
the more significant ones. These 9 also allow me to highlight the problems to date in 
the quality of published evidence regarding prognosis of intracranial cavernomas 
(table 7). 
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MRI yes yes No 133  haem rate 5yrs 92% 
The nature, frequency and natural history of intracranial cavernous malformations in adults 
 
A systematic review of the literature on intracranial cavernous malformations 56 
 
 
At this point, I must highlight that I will deal firstly with untreated prognosis. I will 
look separately at the treatments available and outcomes post treatment. 
 
Diagnostic certainty and cohort size >50 were the only features of the studies where 
they all met with my desired standard.  Beyond that there was uniform failure of any 
study to be population based. All were based in single, mostly tertiary, referral 
centres. This introduces a variety of potential biases such as centripetal, popularity, 
referral filter and diagnostic access biases. All have the same effect- potentially 
generating patient samples that are much different from those found in the general 
population. The likelihood in this setting is that the cases being referred, very often 
for treatment, would be more severe than those found generally in the population. 
Any conclusions drawn on a cohort like this would overestimate the pessimism of 
prognosis of that disease. 
 
Assembly of an inception cohort (inclusion at an early and uniform point of the 
disease) is key in a study of clinical course and prognosis. Failure to do this can have 
an unpredictable effect on the results. If focusing only on those who are at the severe 
end of the spectrum and being referred for any potential treatments, the likelihood is 
that the milder cases who never reach tertiary neurosurgical centres will not be taken 
into consideration and the prognosis will seem gloomier than the reality. It can also 
have the opposite effect however. Supposing there are many patients who are 
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severely disabled at presentation and considered unsuitable for referral to a 
neurosurgical centre, or even those who die at presentation never getting to the 
tertiary centres, then the opposite can occur. Those being referred on for treatment 
may be a select group who have survived the worst and are likely to do better 
anyway.    
 
Objective outcomes and prospective data collection are interlinked. For the person(s) 
deciding on the presence or absence of a particular outcome, clear unambiguous 
definitions should exist and preferably they should be blinded to any potential 
prognostic factors of importance. As human beings we are susceptible to a greater or 
lesser degree to expectation and diagnostic-suspicion biases but good methodological 
practices should minimize these effects. Also, having clear uniform definitions of 
outcomes in use across the literature should make it easier to compare and combine 
studies leading to greater powered results. This is the aspiration of the Angioma 
Alliance Scientific Advisory Board when they tackled the definition of haemorrhage 
in 2008 [Al-Shahi, 2008]. 
 
Completeness of follow-up cannot be over emphasised. All members of the inception 
cohort should be accounted for at the end of the follow-up period as patients do not 
disappear from a study for trivial reasons – they recover, die, move away or get fed 
up but all of these situations influence prognosis. 
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As evident from table 7 there is no perfect study of prognosis and with all the 
varying flaws, this is probably why, for example, results of haemorrhage rates vary 
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Table 7 Haemorrhage rates and definitions in major studies of prognosis 
 Haemorrhage rate N Details of rates Comment 
Robinson 
1991 
I. 0.7% per year per lesion 66  I. 1 bleed in follow up of 143 lesion 
years 
I.  Retrospectively ascertained. 
Aiba 1995 I. 0.39% per year 
II. 22.9% per year per lesion 
III. 1.5% per year 
110 I. 1 case in 254 yrs of follow up 
II. 26lesions out of 62 lesions caused 45 
bleeds over a mean of 3.12 years of  
follow up 
III. 4 pts out of 62 pts over 262patient 
years of follow up 
I. 1st bleed in pts presenting with epilepsy based on the follow-up 
period 
II. Re-bleed rates per lesion in pts presenting with haemorrhage over a 
follow-up period of 3.12yrs 
III. Haemorrhage rate from coexisting lesions in pts who presented 
with haemorrhage from a different lesion 
Kondziolka 
1995 
I. 1.3% per year 
II. 2.63% per year 
III. 0.6% per year 
IV. 4.5% per year 
122 I. 61haemorrhages in 122 patients in 
4550.6 patient years 
II. 9 bleeds in 341.6 patient years of 
follow up 
III. 1 bled out of 61pts but no clear info on 
length of follow up 
IV. 8 bleeds in 7 pts and no clear info on 
the period of follow up 
I. Retrospective haemorrhage rate assuming lesions present from birth 
& counting one bleed per patient 
II. Prospective bleed rate based only on the prospective follow-up 
period & counting multiple bleeds per patient 
III. Bleed rates in those without prior haemorrhage (other presentation) 
IV. Bleed rate in those with a prior haemorrhage 
Porter 1997 I. 1.6% per year 
II. 3.1% per year 
III. 0.4% per year 
173 I. 7 bleeds in 110pts with 427 
patient/years of follow-up 
II. 6 bleeds in 79 pts with mean follow-
up of 16months 
III. 1 bleed in 31pts with unclear follow-
up period 
I. Overall annual rate of bleeding during follow-up 
II. Haemorrhage rate in those presenting with haemorrhage or focal 
neurological deficit 
III. Rate in the group presenting with presentations other than 
haemorrhage or focal neurological deficit 
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Table 8 continued 
 
Study Haemorrhage N Details of rates Comment 
Kim 1997 I. 2.3% per year (1.4% per 
lesion per year) 
II. 3.8% per year (2.6% per 
lesion per year) 
62 I. No clear detail of number of  bleeds or 
of group size but there was 2509.6 
patient years of follow-up 
II. 2 bleeds in 28pts with mean 22.4 
months follow-up 
I. Retrospective rates assuming a constant annual rate since birth 
II. Rebleed rate 
Abdulrauf 
1999 





3.1% per year 68 11 haemorrhages in 68pts with 352.9 patient-
years of follow-up. 
Based on prospective follow-up 
Barker 
2001 
I. 14% in the 1st year after 
first bleed 
II. 34% 2 years later after 1st 
bleed 
III. 56% 5 years later after 1st 
bleed 
IV. 72% 10 years later after 
first bleed 
141 82 re-bleeds in 141pts. Some were multiple 
bleeds in the same patient. No clear details of 
follow-up 
I. Retrospective study. All patients had presented with bleeding so these 
are really cumulative re-haemorrhage rates over time 
Cantu 2005 1.71% per patient per year 133 78 bleeds in 133pts with 4561 patient-years of 
follow-up 
Retrospective haemorrhage rate assuming that cavernomas are 
congenital 
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In the context of cavernoma outcomes during untreated follow-up, in particular 
haemorrhage excites a lot of interest because of its potentially devastating 
consequences. What patients really need to know is what the first ever haemorrhage 
rate is and, also, what the  re-haemorrhage rates of untreated cavernomas are. I have 
listed the various ‘haemorrhage rates’ published in the largest and best studies of 
prognosis (table 8). There is an enormous variation between studies. Much of the 
difficulty is with the varying selection of patients which leads to very different types 
of cohorts and consequently very different outcome rates.  
 
Compounding this problem is the variety of methods used to calculate haemorrhage 
rates (table 8). Is it retrospective or prospective data collection, per lesion or per 
patient rates, first ever haemorrhage, re-haemorrhage or a combination of these, and, 
last but not least, is it clear what denominator is used to calculate haemorrhage rate? 
For many studies there is an assumption that cavernomas are congenital and 
therefore the denominator used is the period of exposure to risk of outcomes being 
from birth to presentation. However it is now clear that cavernomas are acquired at 
an unpredictable time throughout life which makes estimation of the period at risk of 
outcomes much more complex. A much more realistic approach, although imperfect, 
is to take the period at risk of outcomes from the date of presentation to the end of 
prospective follow-up.  Most rates are formed from a combination of these features 
but this makes comparison between studies very difficult and no study on its own is 
powered enough or representative enough of the general population to draw 
clinically useful conclusions.  
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Another major issue that is mentioned in section 3.4 on presentation, it is the lack of 
uniformity between studies on what constituted a definition of an objective 
outcome/clinical event, such as haemorrhage, focal neurological deficit and epilepsy. 
This clearly impedes meta-analysis or even informal comparison between studies and 
is likely to be responsible in part for the variation in prognosis in the literature to 
date. The importance of improving this flaw in studies thus far has been addressed in 
terms of haemorrhage by the Angioma Alliance Scientific Advisory Board [Al-
Shahi, 2008] but also in epilepsy in the article by Josephson [Josephson, 2011]. 
 
A final idea arising from my review of the literature is whether any studies identify 
significant prognostic factors. Currently cavernoma location (i.e. brainstem etc.), 
previous haemorrhage and being female have all been raised as potential prognostic 
factors of interest but no study is powered enough or appropriately designed to 
answer these questions definitively. As illustrated in a paper by Counsell et al 
[Counsell, 2001], for a study of prognosis to be large enough to identify variables 
that predict a certain outcome there has to be a ratio of at least 10 outcomes to one 
potential prognostic variable. Therefore to test a prognostic model with two variables  
one must have at least 20 outcomes of interest. In disease such as intracranial 
cavernomas the condition is sufficiently rare and the occurrence of outcomes such as 
haemorrhage sufficiently infrequent to result in many studies being inadequately 
powered to determine a reliable prognostic model. The solution is to have a large 
cohort of patients or a smaller cohort that one follows for a very long time. Either 
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option is not easily attainable and likely explains why we don’t have well developed 
prognostic models to date.  
 
3.5.3 Conclusion 
Operating in isolation without consensus definitions among the research community 
interested in cavernomas just leads to ambiguous outcomes from small studies that 
are difficult to translate into clinically useful information. For the future, widespread 
agreement on a clinically relevant outcome definition would have beneficial 
implications not just for one study but for all the patients and researchers interested 
in this area. 
 
3.6 Treatment in the literature 
There are three ways to treat intracranial cavernous malformations – surgical 
excision, radiosurgery (LINAC or Gamma knife), or to do nothing but medically 
manage symptoms. There are technical considerations to take into account when 
pondering the merits of surgical excision versus radiosurgery but I want to take one 
step back and consider the debate about whether to intervene at all. We would do 
well at this point to bear in mind the historic Hippocratic Oath - First do no harm! 
 
What is published in the literature to date are multiple case series reporting benefit to 
highly selected groups of patients based almost exclusively in single surgical centres. 
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There are no randomized controlled trials for treatment of cavernous malformations 
published in the literature [Chapter 3, Section 3.2]. However I note that in January 
2013 a center in New Mexico has registered the first trial of medical treatment 
aiming to reduce risk of haemorrhage in the familial form of cavernomas 
(http://clinicaltrials.gov).  While we await this trial we must make do with the 
available published data which has belying it an assumption that we know what the 
untreated prognosis of cavernomas is and therefore know who to select to benefit 
from what treatments we have. I would seriously dispute this for the reasons outlined 
in my thesis so far.  
 
There is another fundamental problem with drawing any conclusions from the 
published data. There is no doubt that literature is heavily influenced by publication 
bias [Easterbrook, 1991]. The temptation by researchers to seek to publish good 
results and also by editors and reviewers to publish papers that have something new 
to offer is very real indeed. With certainty we can say that both surgical excision and 
stereotactic radiosurgery are not benign interventions. They carry a real morbidity 
and also mortality. If patients are to make an informed, rational choice about 
proceeding to active intervention versus none they need to balance up the known 
untreated prognosis of cavernomas and the known risks and benefits of surgery in 
some form. I would argue that we have insufficient evidence of all three of these 
factors. 
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There is no doubt that there will be a subgroup of patients who will ultimately benefit 
from a form of treatment. The challenge lies with us to hold our nerve, establish good 
evidence of untreated prognosis and then, and only then, pursue who is best to select 
for surgical treatment. A randomized controlled trial is the only robust way to do this 
but I am unsure whether this will ever come about in reality, in part because many of 
these patients are under the care of neurosurgeons!   
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Chapter 4:  
The incidence of intracranial cavernous malformations in 
SIVMS 
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4.1 Introduction 
The Scottish Intracranial Vascular Malformation study (SIVMS) was set up in 1998. 
It is a prospective, population-based disease register recruiting incident cases of 
intracranial vascular malformations in Scotland [Al-Shahi, 2003]. Although all major 
types of IVMs were recruited and followed in SIVMS, this thesis refers only to those 
intracranial CMs recruited between January 1
st
 1999 and December 31
st
 2003. As my 
systematic review of the literature revealed, there are major methodological flaws in 
the designs of studies published in the literature to date. SIVMS was designed to 
minimise these issues and the impact they would have on results. Therefore it is 
important for me to outline the methods of SIVMS relevant to each topic under 
discussion in each chapter, justifying why it is the ideal vehicle for data collection for 
this thesis.  
 
4.2 Patient recruitment (SIVMS) 
At the time of this project in the UK, multicentre research was defined as taking 
place over five or more local research ethics committees (LREC) geographical 
boundaries, each LREC usually corresponding to a part or the whole of a health 
board. Therefore the creators of SIVMS had to submit an application for ethical 
approval to a multicentre research ethics committee (MREC) for adjudication on the 
ethical and scientific merit of the project. Once approved (MREC/98/0/48), it had 
then to be distributed to every LREC in Scotland to judge the suitability of the local 
site, researcher(s) and facilities before the research could start in their area. 
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The methods used in the study are founded on the widely accepted good practice for 
a study of incidence and prognosis as outlined in Sackett’s Clinical Epidemiology. 
Scotland's population is a manageable size for such a study and should provide 
adequate numbers for meaningful data analysis with an estimated incidence for 
intracranial vascular malformations (IVM's) of 1 to 2.5 per 100,000 of the population 
per year [Al-Shahi, 2003]. 
 
There are four neuroscience centres in Scotland based in Glasgow, Edinburgh, 
Dundee and Aberdeen. The clinicians, radiologists and pathologists working in 
clinical neurosciences and stroke medicine provided the main source of cases for 
SIVMS, based not only at these four neuroscience centres but also at other hospitals 
throughout the country. Collaborators received monthly newsletters and regular 
reminders about the study by e-mail and postcard. The SIVMS steering committee 
updated quarterly lists of potential new collaborators.  
 
 In January 2000, my predecessor, Dr Rustam Al-Shahi, contacted all 3,700 GPs in 
Scotland and asked directly whether any of their patients harboured an IVM. Replies 
were cross-checked with the patients already known to this study. As the yield of 
new patients was so low this process was not repeated during my tenure of the 
Research Fellowship. 
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Few patients receive healthcare outside the National Health Service (NHS) in 
Scotland and there is negligible overseas or cross-border travel to England for 
healthcare. In Scotland every episode of hospital care is coded by the information 
and statistics division (ISD) of the NHS with details of a patient’s main diagnosis, 
comorbidity (up to 5 subsidiary diagnoses), and any operations/procedures 
performed. These are coded using the 10th revision of the International Classification 
of Diseases (ICD-10) and are known as the Scottish morbidity records (SMR01). 
Since 1980 these are linked by the ISD with the death records from the General 
Register Office (GRO). SIVMS, every six months, received from the ISD records of 
every person aged 16 or more years either dying or discharged from hospital with an 
intracranial vascular malformation(s) (IVM). The ISD data supplied in July 2004 
completed the dataset from January 1999 to December 2003 (inclusive) and are used 
in this thesis. 
 
My main duties as the Research Fellow were to collect and review all the clinical 
material of cases notified to SIVMS by the multiple overlapping sources of case 
ascertainment. Then I would arbitrate with the relevant expertise where there was 
doubt about whether the case met the criteria for inclusion in SIVMS. 
 
Only adults (≥ 16 years) have been included in SIVMS because of the different 
consent procedures for children and also the likely differing aetiology of cavernomas 
presenting in childhood and their possible differing prognosis.  
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4.3 Diagnostic criteria (SIVMS) 
Inclusion in SIVMS necessitated meeting the following criteria at the time of 
diagnosis (table 9): 
 
Table 8 SIVMS inclusion criteria 
SIVMS inclusion criteria 
 Any of the principal subtypes of IVM1 
 Cavernous malformation (CM) 
 Venous malformation (VM) 
 Brain AVM 
 Dural AVM 
 Date of first-in-a-lifetime diagnosis (by imaging or histology) ≥ 1st January 1999 
 Age ≥ 16 years at the time of this diagnosis 
 Permanently resident in Scotland at the time of this diagnosis 
1 
SIVMS recruits adults with any type of IVM, but this thesis only deals with cavernous 
malformations. 
 
The last two criteria were usually met at notification. Whether it was a new diagnosis 
or not was concluded by the Research Fellow after review of the clinical casenotes. 
Definite diagnosis was made based on radiology or pathology and will be discussed 
in more detail here. 
 
Calcification, or an area of high attenuation without any surrounding oedema on CT 
imaging can raise the possibility of a cavernous malformation but this is not enough 
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to regard it as a definite diagnosis. Definite features on MR imaging are what is 
required to make it a ‘definite’ radiological case included in SIVMS. The particular 
features on MR were described by Zabramski et al in 1994 and are listed in section 
1.3.3, table 1 Chapter 1 [Zabramski, 1994].  
 
It is not always the case that investigations, whether radiological or pathological, 
establish a diagnosis of cavernous malformation beyond all doubt. Brain cavernomas 
may be uncertain on imaging because radiological investigation is limited i.e. 
inadequate MR sequences have been performed, incomplete imaging follow-up over 
time etc. This can happen for a variety of reasons. It may have been clinically 
inappropriate to pursue the diagnosis any further, the patient may have declined it, or 
more appropriate imaging was not available although this is less likely with the more 
widespread availability of MR imaging today. If the patient presents with a large 
intracranial haemorrhage this can often obscure the underlying lesion and, usually, it 
is with time and repeated follow-up imaging that it becomes evident. 
 
Inevitably also, certainty of radiological diagnosis is affected by variation between 
observers reflecting experience and subspecialty interests. For these reasons, the final 
decision about radiological certainty of diagnosis was taken collectively after review 
of all diagnostic imaging. Certainty was arbitrated at consensus meetings between 
the SIVMS Research Fellow and the two consultant neuroradiologists (Dr Robin J 
Sellar, Western General Hospital, Edinburgh and Dr Jo J Bhattacharya, Southern 
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General Hospital, Glasgow). If any SIVMS participant was found to have received 
an incorrect diagnosis of a brain cavernoma after review of all imaging they were 
then excluded. The consensus decision subcategorized ‘included’ cases into 
‘definite’, ‘probable’ and ‘possible’ to facilitate prospective clinical follow-up in the 
knowledge that some of these cases, with subsequent imaging, might become 
‘definite’ cases in the future. 
 
On the other hand certainty of pathological diagnosis was determined from 
pathologists’ reports of autopsies and specimens from surgical excision, and was not 
subject to independent review. 
 
For the purposes of data in this thesis however I included only cavernomas with a 




4.4 Procedural protocol on receipt of notification of a new case (SIVMS): 
Following notification of a newly diagnosed patient SIVMS contacted the patient’s 
GP and consultant by post. An interval of four weeks from notification was allowed 
to elapse for a discharge summary and /or brain imaging report to reach the clinician 
before contact was made. A structured letter sought confirmation of the accuracy of 
the information supplied by the notifier, permission to access the patient’s case notes, 
and questions about whether the patient was suitable for SIVMS to approach by post 
with a consent pack [Appendix 2 & 3].  
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Non-responders were contacted by a three-week reminder letter, and again contacted 
by letter or telephone if necessary [Appendix 4]. 
If access to case notes was denied on the grounds of cost by a GP, SIVMS negotiated 
reimbursement and/or agreed to go to the practice to copy the notes. If access to case 
notes was conditional upon patient consent and the patient had not been deemed to 
be aware of their diagnosis, SIVMS attempted to gain access at that time to the notes 
by reassurance that explicit patient consent was not required for this by MREC in 
Scotland [Appendix 5]. 
 
Disagreements between GP and consultant about whether SIVMS should approach a 
patient with the postal content pack was of most concern because SIVMS strove to 
obtain consent and questionnaire data from every living patient. SIVMS had little 
choice but to refrain from approaching the patient when a clinician’s opinion was 
that they had been reassured about their prognosis and would be worried by an 
approach from a research study, or that the patient was too anxious or cognitively 
impaired for postal contact. However, annual GP follow-up was used as an 
opportunity to review the appropriateness of these decisions. For a patient to be 
approached with a consent pack they must have been alive, aware of their diagnosis 
and deemed appropriate for postal contact. Ethics committees regarded direct first 
communication from the research study to a patient to be unethical (so-called 'cold 
calling,'). For this reason SIVMS sent a patient consent pack to the patient's GP, 
asking the GP to sign a preformatted letter introducing SIVMS and then to forward 
this letter with the consent pack in a prepaid envelope addressed to the patient 
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[Appendix 6]. The consent pack contained a letter from SIVMS to the patient, a 
consent form, and information leaflet about SIVMS, and a questionnaire requesting 
simple demographic details [Appendix 7]. On the consent form, patients were asked 
whether they permitted access to their medical records and whether they were willing 
to complete annual questionnaires. If necessary, up to two reminders were sent to the 
GP at three-week intervals. If there was still no response from the patient after a 
further six weeks, attempt to gain their consent and completion of the questionnaire 
was abandoned until the annual follow-up procedure started. 
 
At least four weeks after diagnosis, SIVMS enquired about the extent of brain 
imaging at the hospital where the diagnosis was made (and the referring hospital, if 
appropriate). The relevant CT, MRI and IADSA (Intraarterial digital subtraction 
angiography) studies were requested by telephone, and if they were not received 
within three weeks, non-responders were contacted by telephone again. Once 
received, hard copies of each completed imaging study were made and transported to 
the image library filing cabinet at the Institute of Neurological Sciences in Glasgow 
to await review by the study neuroradiologists at their consensus meetings with the 
Research Fellow. 
 
In conclusion, SIVMS, as a population-based study with multiple overlapping 
sources of case ascertainment and robust criteria for diagnosis and inclusion, was the 
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ideal vehicle for estimation of incidence of intracranial cavernous malformations in 
adults. 
 
4.5 Incidence in SIVMS (1999 – 2003) 
 
4.5.1 Introduction 
Incidence of cavernomas in SIVMS has been estimated for the first two years (1999-
2000) [Al-Shahi, 2003]. However, this thesis focuses on cavernomas alone and the 
following results are based on 5 years of incidence data, from January 1999 to 
December 2003. The aim is to establish a more robust estimate of incidence with 
tighter confidence intervals. Only cases that have a definite diagnosis on imaging or 
pathology on December 31
st
 2003 are included for the purpose of incidence rate 
estimation for this thesis.  
 
The most recent and time-relevant decennial census available for Scotland was 
conducted on 29
th
 April, 2001. At that time, the total population was 5, 062, 011 of 
whom 52% were female. 4, 089, 946 (80.8%) were aged≥ 16 years, and 87% were 
born in Scotland. The size and age structure of the Scottish population for other years 
of the study were derived from annual between-census estimates. The General 
Register Office (GRO) produces these estimates using registration of births and 
deaths as well as data on immigration and emigration (www.gro-scotland.gov.uk). 
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Statistical analysis was done using SPSS software version 11.0 or 16.0. Confidence 
intervals were calculated using Altman’s Statistics with confidence (2
nd





 1999 and December 31
st
 2003 there were 220 notifications to the 
study of potential incident brain cavernomas in Scotland. A breakdown of the 
notification sources is demonstrated in figures 5 & 6.  
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The nation-wide collaborative network contributed by far and away the most (97%). 
ISD did not contribute any cases that the collaborative network had omitted. GPs 
were surveyed with a specific single mailshot in 1999 but this yielded one case that 
no one else had notified to SIVMS. This exercise was not repeated after 1999 as the 
yield was not of a sufficient size to justify the workload. Also, at that point the study 
was established and well-advertised and it was felt that a dedicated annual mailshot 
was not required. 
 
Of the 220 notifications to SIVMS, 205 related to cases that were subsequently 
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case notes, diagnostic brain imaging and pathology reports were scrutinized. Fifteen 
notifications were excluded for various reasons which are illustrated in Figure 7.  Of 
the 205 included notifications, 177 referred to definite and 28 to uncertain cases. 
Only definite cavernomas were included for the purposes of incidence estimation and 
177 notifications translated into 137 definite cases since some cases were notified by 
more than one source. 
 





Since some cases were notified by more than one source, 177 notifications translated 
into 137 definite cases. 
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In our study population there were 137 incident, or newly diagnosed definite cases of 
brain cavernomas in the Scottish population over the period 1999 – 2003. This 
equates to an overall crude incidence of 0.67(95% CIs, 0.56 to 0.79) per 100,000 
adults per year. The adult population mid-year estimate for Scotland was used as the 
denominator (http://www.gro-scotland.gov.uk/). The crude incidence for each year 
was also calculated and is illustrated in figure 8. 
 
Figure 8 Crude incidence for each year of the study based on the mid-year 




The incidence rates appear to increase year on year for the first three years of the 






































Years of study 
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to relate to bedding in time for the study. In 2002 there was a dip but this may have 
been due to factors such as a change in Research Fellow and the inevitable lag in 
study publicity during the transition period from one Fellow to another. Rates for 
2003 again met the peak rates from 2001. The certainty of these patterns is shaky 
however as all confidence intervals overlap and the findings may be just chance. 
Incidence of symptomatic brain cavernomas was 0.36 (95% CIs, 0.28 to 0.45)  per 
100,000 adults per year. Incidence of asymptomatic brain cavernomas was 0.24 
(95% CIs, 0.24 to 0.4). 
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There appears to be a trend towards peak incidence between the ages of 25 and 55 
years although with the overall small numbers (137 cases) confidence intervals again 
overlap (Figure 9). 
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There was no evident significant difference between males and females in different 
age bands (Figure 10).  
 
Figure 10 Age and sex specific incidence for brain CMs in SIVMS with either 
upper or lower limit of each 95% CI shown for clarity 
 
 
The incidence for SIVMS, was age standardized against two reference populations. 
Firstly, the UK population in the 2001 census 
(http://www.statistics.gov.uk/census2001) and, secondly the USA population in the 
2000 census (http://www.census.gov). The incidence rates did not vary significantly 
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both reference populations and also that our study crude incidence can be translated 
onto other populations.  
The crude incidence was not standardized for sex as there does not appear to be a 
significant difference between the sexes in our population or in those reported in the 
wider literature (Fig 10). 
 
4.6 Discussion 
As illustrated in my systematic review of the literature methodologically robust 
studies of the incidence of sporadic cavernomas is significantly lacking. The 
weaknesses of the studies which are in existence are not from lack of enthusiasm by 
the researchers but possibly reflect the particular difficulties of doing 
epidemiological research constrained by availability and cost of resources and also 
by the ethical issues involved in screening populations for asymptomatic diseases, in 
particular, diseases where the best course of action, once a diagnosis is established, is 
not clear.  
 
SIVMS is significant as the first prospective, population-based study to estimate 
crude incidence based on five years of recruitment; 0.67(95% CIs, 0.56 to 0.79) per 
100,000 adults per year. This result is not dissimilar to incidence in the only other 
truly population based, but retrospective study reported in the literature, 0.5(95%CIs, 
1 to 1.0) per 100,000 per year based on a period when MR imaging was available 
[Brown, 1996]. The incidence calculated by Brown’s study including the period prior 
The nature, frequency and natural history of intracranial cavernous malformations in adults 
 
The incidence of intracranial cavernous malformations in SIVMS 84 
 
to MRI availability, resulted in an incidence of 0.17(95% CIs, 0.34 to 1.0).  This 
highlights the increasingly significant role that MR plays in the diagnosis of these 
lesions. Interestingly in the 10 year period between Brown’s study and SIVMS, 
despite the availability and more widespread use of MR, the rates of incidence in 
SIVMS did not appear to be that much greater.  
 
The comparison of the incidence of symptomatic intracranial cavernomas in SIVMS, 
0.36 (95% CIs, 0.28 to 0.45) per 100,000 adults per year, is probably best done with 
the estimated symptomatic incidence from a single surgical centre - 0.32 per 100,000 
adults per year [Mathieson, 2003].  
 
In SIVMS the cohort split between symptomatic and asymptomatic was 53%:47%. 
In Brown’s population based study it was 40%:60%, not significantly different. 
However in Mathieson’s Swedish study, although they claimed it to be population 
based, the split was 80%;20% which is more likely to reflect the fact that it was a 
single series from a neurosurgical centre. I suspect the truth lies somewhere closer to 
our split and Brown’s split although the numbers are so small that only time will tell. 
Variation in the use and availability of MR will continue to plague studies of this 
nature but eventually with time and larger studies the truth will out. 
 
As discussed previously, the holy grail of studies of incidence is complete case 
ascertainment. Although SIVMS is still susceptible to the biases imposed by the 
The nature, frequency and natural history of intracranial cavernous malformations in adults 
 
The incidence of intracranial cavernous malformations in SIVMS 85 
 
variable practice between clinicians of investigation of symptoms with imaging and 
also the potential elusivity of asymptomatic cavernomas, I believe that our 
comprehensive method of overlapping sources of case ascertainment brings us as 
close as is currently possible to a true estimate of crude incidence.  
 
To date, the published literature has not raised the possibility of a difference in 
incidence between the sexes and our results continue to bear this out. Initially, when 
I came to the project I presumed that the incidence of cavernomas would be 
significantly greater in young adults due to the pursuit, in clinical practice, of 
vascular malformations in young stroke victims. Our study suggested a possible 
tendency for this to be the case but confidence intervals overlap and our results 
certainly don’t hold this to be definitively true.    
 
Another weakness of SIVMS is the inevitable omission of cases deemed too ill/old 
for further investigation when presenting with haemorrhage and also those with 
symptoms too mild for investigation. This, however, is inevitable but the likelihood 
of these numbers being very small is a source of consolation. 
 
Detection rate versus incidence has been raised in the published literature [Al-Shahi, 
2003]. It is true that what we term incident cases are those coming to light for the 
first time after 1999, whether symptomatic or incidental findings. Although not 
congenital lesions, cavernomas can exist silently for some time and, therefore, are 
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more correctly termed prevalent cases. What we call incidence is in fact detection 
frequency. This is true for many diseases however. Often they exist silently before 
coming to clinical attention and I believe it is confusing, therefore, to use the 
semantically correct term ‘detection frequency’ instead of the more widely used and 
applicable term ‘incidence’. 
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Chapter 5:  
The presentation of intracranial cavernous malformations in 
SIVMS 
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5.1 Introduction 
The population-based design of SIVMS was ideal to evaluate the relative 
contribution each subtype of cavernoma presentation makes to the overall disease 
burden in the Scottish population. As the first multicentre, population-based study 
SIVMS was breaking new ground. 
 
5.2 Presentation coding in SIVMS 
Presentation, or inception into SIVMS, was recorded as the date of the symptom 
onset that directly lead to a medical evaluation that in turn prompted investigation 
and a subsequent cavernoma diagnosis. This was the date from which prospective 
follow-up began. The SIVMS Research Fellow reviewed all available casenotes and 
then recorded this date in the Microsoft Access database. 
 
At the point where the Research Fellow reviewed the case notes he/she also recorded 
all the new onset symptoms potentially referable to the cavernoma as clinical events 
in the database. One such event would correspond to the presentation date in the 
database and this was how the presentation type was coded for each case in SIVMS. 
Each clinical event was also coded as ‘definitely’ or ‘possibly’ caused by the 
cavernoma. At this point also a baseline Rankin score was allocated by the Research 
Fellow derived from information in the case notes only [Bamford, 1990].   
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The study design had pre-specified ‘types of clinical events’ felt to be relevant to 
cavernomas. Events such as ‘haemorrhage’ that were easily referable to a cavernoma 
were included but also events such as ‘headache’ where the causal relationship is far 
less clear. As two different Research Fellows were coding the data collected over 
five years clear definitions of each type of clinical event were in place prior to patient 
recruitment. 
 
The clinical events recorded in SIVMS, of which one event would correspond to 
presentation mode for each patient, were as follows (Table 10): 
 
Table 9 Presentation/clinical event subtypes in SIVMS 




Focal neurological deficit persistent 
Focal neurological deficit progressive 
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As the SIVMS Research Fellow for two and a half years, whenever doubt existed in 
my mind as to how an event/presentation should be coded, the pertinent information 
was also reviewed by my supervisor, Professor Warlow, and agreed. For the data 
presented in this thesis the definitions used for coding were as follows; 
 
5.2.1 Incidental 
This was coding in the database used for presentations only. There are a few 
situations when an individual had brain imaging for a completely separate reason and 
an incidental cavernoma was noted, for example when an individual was acting as a 
control in a brain imaging study for a purpose unrelated to SIVMS or they had a 
significant head injury requiring imaging. It may also have been that they had some 
focal neurology such as unilateral sensorineural hearing loss that was definitely 
unrelated to the cavernoma. 
 
5.2.2 Intracranial haemorrhage 
Clinical features of intracranial haemorrhage with radiological, pathological or 
surgical evidence, or rarely, only cerebrospinal fluid (CSF) evidence of recent 
haemorrhage. Radiological proof of acute haemorrhage was fresh blood of high 
density on CT and/or high signal methaemoglobin on T1-weighted MRI. Very 
occasionally there was no supplementary evidence supporting a very strong clinical 
suspicion of haemorrhage and these were coded as ‘clinically probable’ 
haemorrhages. 
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5.2.3 Infarction 
Classified according to the Oxfordshire Community Stroke Project (OCSP) 
classification as involving the total/partial anterior circulation, lacunar or posterior 
circulation. 
 
5.2.4 Focal neurological deficit (FND)  
These were defined as clinical impairments referable to the anatomic location of the 
cavernoma, that were neither definitely post-ictal nor found to be due to haemorrhage 
or infarction after timely radiological investigation. What constituted timely 
radiological investigation was more of a pragmatic decision rather than a precise 
time cut off. It is widely accepted that acute blood transforms from hyperdense to 
isodense anywhere between 1 to 6 weeks on CT and the signal changes of blood on 
MR are even more difficult to age in a clinically meaningful way [Bradley, 1993]. 
Therefore in our study we took ‘timely’ to mean onset of symptoms within 1 week of 
the scan date (CT in all cases). But if the temporal relationship between symptoms 
and scan was 8 days and the clinical picture and CT images supported the diagnosis 
of haemorrhage then it was coded accordingly in the SIVMS database after our 
consensus meetings with the two neuroradiologists.  
FND – persistent (>24hours) 
FND – progressive(>24hours with further deterioration) 
FND – transient (lasting <24hours) 
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Difficulty arose in distinguishing clinically probable haemorrhages from focal 




Any occurrence of an epileptic seizure was classified according to the revised 
International League Against Epilepsy 
 
Subtypes of epilepsy 
 Simple partial +/- secondary generalisation 
 Complex partial +/- secondary generalisation 
 Generalised 
 Status epilepticus 
 Unknown 
 
This was recorded within the limits of the data available in the patient’s case notes or 
from a patient’s annual postal epilepsy questionnaire. Information was also recorded 
at every opportunity in the notes or in questionnaires about epilepsy activity, 
treatment and timing of seizures. 
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5.2.6 Headache 
Type of headache was classified according to the International Headache Society 
(IHS) classification. In SIVMS most headaches were recorded as migraine, tension-
type headache or unknown. An estimate of frequency was also recorded where 
possible from case notes or questionnaires. As this was a very difficult symptom to 
attribute to cavernomas, it’s cause was always recorded as ‘unknown’ in the database 
pending resolution of this issue in the literature. 
 
5.2.7 Cognitive impairment 
This was simply recorded from the case notes without quantification of severity. The 
aetiology of this event was also recorded as ‘unknown’. 
 
5.2.8 Other 
It encompassed a variety of symptoms and signs that may have been attributable to a 
cavernoma but did not fall under any of the other categories. 
 
Each presentation was coded according to these ten categories and a causal 
relationship between the event and the cavernoma was also assessed. Much of the 
analysis focuses on symptomatic versus asymptomatic presentation as clinically this 
division is often of interest. Throughout this thesis incidental presentations are 
interchangeable with asymptomatic presentations of cavernomas.  
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5.3 The presentation of cavernomas in SIVMS 
Between January 1999 and December 2003 there were 139 prospectively collected 
definite cavernoma cases included in SIVMS (Two cases who presented in 
December 1998 were included in this analysis but were not included in the incidence 
analysis – n = 137). The presentation details of 138 were available for inclusion in 
this thesis. One patient’s details were missing from our analysis as the notes were not 
available to me at the time of writing despite considerable efforts to get them. The 
details of the assembled cohort are as follows:  
 
5.3.1 Descriptive statistics 
5.3.1.1 Sex 
78 (56%) were female and 61 (44%) male 
 
5.3.1.2 Age at first presentation  
Table 10 Age at first presentation 
Data available 138/139 patients 
Mean 44 
Standard deviation 16 
Median 40.5 
Interquartile range 32 to 53 
Minimum, maximum 17, 83 
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5.3.1.3 Mode of presentation  
Table 11 Mode of presentation 
Mode of 
presentation 
n (%) n (%, 95%CI) of all 
presentations 





 65 (47%) 65 (47%, 39% to 55%)  
Symptomatic
2
 73 (53%)   
Epilepsy - 34 (25%, 18% to 32%) 34 (47%, 36% to 58%) 
FND(all types) - 21 (15%, 10% to 22%) 21 (29%, 20% to 40%) 
Haemorrhage - 18 (13%, 8% to 20%) 18 (25%, 16% to 36%) 
Total 138 (100%) 138 (100%) 73 (100%) 
1
 ‘Asymptomatic/Incidental’ presentations constitute the group of cases with a 
presentation clinical event such as headache, other, infarction, tinnitus/bruit, 
cognitive impairment, epilepsy, incidental or FND persistent/progressive/transient 
but all of which were coded in the database as ‘not caused by the CM’ or it was 
‘unknown’ whether the CM was responsible or not.  
2
 Symptomatic presentations were those anatomically corresponding to the known 
cavernoma and therefore could reasonably be assumed to have caused the symptoms. 
 
If there was more than one symptom then the most clinically relevant symptom at 
that time was used to code the mode of presentation. Also, when the situation arose 
where a patient presented with a seizure but it was found to be due to acute 
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haemorrhage, then their presentation was coded as haemorrhage as this was felt to be 
the root cause of the symptom.  
 
5.3.1.4 Incidental presentation by the year of first diagnosis 
There did not seem to be a definite pattern over time. However, the possible 
reduction in numbers of ‘incidental’ cases reported to the study in 2001 may again 
reflect the wind down period of the first research fellow (table 13). 
 
Table 12 Incidental presentation by year of first diagnosis 
 1999 2000 2001 2002 2003 Total 
Incidental N % N % N % N % N % N % 
Yes 13 59% 15 58% 10 30% 10 43% 17 50% 65 47% 
No 9 41% 11 42% 23 70% 13 57% 17 50% 73 53% 
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5.3.2 Mode of presentation and its relationship to other factors 
 
5.3.2.1 Median age at presentation according to mode of presentation 
It appears that asymptomatic cases may present slightly later than symptomatic cases 
although interquartile ranges overlap to a certain extent (see figure 11 ).  
 



























Mode of presentation 
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 This led me to explore whether a statistical difference existed between the mean age 
of presentation in the asymptomatic group versus the symptomatic group. An 
independent samples t-test was conducted to compare them. There was a significant 
difference in mean age at presentation between both groups (table 14). 
 
Table 13  Mean age in symptomatic versus asymptomatic group 
Mode of presentation Asymptomatic Symptomatic 
Mean age 50 39 
Standard deviation 16 15 
Median 48 36 
Interquartile range 37.5 to 59 27.5 to 48.5 
t statistic (136) = 4.08, p < 0.05 (two-tailed) 
 
This may reflect a greater amount of imaging being performed in older patients for 
unrelated reasons allowing the presence of the cavernoma to come to light or, 
perhaps, incidental cavernomas are acquired with age and cavernomas that are going 
to be symptomatic do so at a younger age. However, does that mean that older 
patients diagnosed with an asymptomatic cavernoma can rest easy that they have a 
more benign condition than those presenting in the fourth decade of life? This was 
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5.3.2.2 Mode of presentation by gender 
 
No significant difference was found between genders when asymptomatic and 
symptomatic presentation groups were compared (Fisher’s exact two tailed test). 
 
Table 14 Mode of presentation by gender 
Mode of 
presentation 
n of males (60) n of females (78) Total n (138) 
 Asymptomatic 29 (47%) 36 (53%) 65 (100%) 
 Symptomatic 31 (42%) 42 (58%) 73 (100%) 
Epilepsy 20 14 34 
FND 6 15 21 
Haemorrhage 5 13 18 
 
In absolute terms, however there was more than double the number of both FNDs 
and haemorrhages at presentation in women. This was an interesting finding 
considering the suggestion in the published literature that women have a tendency to 
haemorrhage more than men [Robinson, 1991] & [Moriarty, 1999]. To question 
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Mode of presentation (haemorrhage or other) and gender  
Chi-squared p-value = 0.24 No statistically significant association between haemorrhagic 
presentation and gender. 
Table 15 Mode of presentation (haemorrhage or other) and gender 
 Female  Male  Total  
Mode N % N % N % 
Haemorrhage 13 17% 5 8% 18 13% 
Other 65 83% 55 92% 120 87% 
Missing 0  1  1  
 
 
Mode of presentation (haemorrhage/FND or other) and gender  
Chi-squared p-value = 0.03 Interestingly once haemorrhagic presentations are grouped 
together with FND presentations it appears that women are statistically more likely to 
present like this than men. This could be because FNDs cause disability like intracranial 
haemorrhage (ICH) or, indeed, FNDs might be occult ICHs. This will be discussed further in 
section 5.4 (Discussion). 
Table 16 Mode of presentation (haemorrhage/FND or other) and gender 
 Female  Male  Total  
Mode N % N % N % 
Haemorrhage or FND 28 36% 11 18% 39 28% 
Other 50 64% 49 82% 99 72% 
Missing 0  1  1  
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5.3.2.3 Mode of presentation by number and types of IVM present per patient 
Since cavernomas are not infrequently multiple and are also well described on 
occasion to be accompanied by a venous malformation (a dilated draining vein), I 
felt it appropriate to explore the effect the presence of either multiple cavernomas or 
a cavernoma plus a venous malformation might have on mode of presentation (table 
18). 
 
The impact of a single CM versus multiple CMs +/- VMs had no statistically 
significant effect on the presentation being either asymptomatic or symptomatic in 
our cohort (Fisher’s exact two tailed test).   
 




(% of total n) 
Multiple CMs 




(% of total n) 
Asymptomatic 49 5 11 
Symptomatic 50 14 9 
Epilepsy 22 10 2 
FND 17 1 3 
Haemorrhage 11 3 4 
Total 99 (72%) 19 (14%) 20 (14%) 
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5.3.2.4 Mode of presentation and the presence or absence of a retrospective event such 
as haemorrhage, epilepsy or FND. 
Although our follow-up in SIVMS was prospective, when surveying the casenotes, if 
an event such as haemorrhage, FND or epilepsy was recorded in the notes prior to 
diagnosis of the CM and entry into SIVMS, we in turn recorded it in the SIVMS 
database. I then sought to investigate whether symptomatic presentations were more 
likely to have a ‘retrospective’ event recorded (table 19).  
Our cohort bears out the hypothesis that the likelihood of symptomatic presentations 
having a previous recorded event (haemorrhage, FND or seizure) was greater than 
asymptomatic presentations. The difference was significant p = 0.025 (Fisher’s exact 
two tailed test).  Interestingly none of the haemorrhagic presentations had any 
recorded previous events. 
 
Table 18 Mode of presentation +/- retrospective event 










Haemorrhage 1 (2%) 2 (6%) 1 (5%) 0 (0%) 
FND 2 (3%) 0 (0%) 5 (24%) 0 (0%) 
Seizure(s) 6 (9%) 13 (38%) 1 (5%) 0 (0%) 
Any type of event 9 (14%) 15 (44%) 7 (33%) 0 (0%) 
 
The nature, frequency and natural history of intracranial cavernous malformations in adults 
 
The presentation of intracranial cavernous malformations in SIVMS 103 
 
5.3.3 Death at presentation 
Six patients died at presentation. None were due to the cavernous malformation 
itself. All six were incidental diagnoses made at the time of the terminal event. Five 
cases were incidental findings on a post mortem when the cause of death varied from 
bleeding oesophageal varices, ruptured iliac artery aneurysm, road traffic accident, 
bronchopneumonia to murder. The sixth person died of a spontaneous, unrelated 




The results from SIVMS are the first from a large, truly prospective, population 
based inception cohort and therefore, I suggest, are the closest to the true natural 
history of cavernomas. Our consistent, clinically relevant and transparent definitions 
of modes of presentation, such as haemorrhage, make our results practical for 
translation into every day clinical practice and also useful for other future studies. 
 
Although haemorrhages and focal neurological deficits are distinct 
presentations/outcomes in cavernomas, there is a certain degree of overlap between 
the two that is important to discuss. This overlap arises from the grey area of when 
someone has symptoms referable to the cavernoma that could fit the clinical scenario 
for either classification and the only distinguishing feature is what is or is not present 
on timely, appropriate imaging. As SIVMS was an observational study, there was no 
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interference in how patients were investigated or managed. The consequences of this 
were that pursuit of timely imaging in patients with pertinent symptoms varied 
depending firstly on when the patient reported the symptoms, who they were 
reported to and what the access to imaging was in that particular region. Therefore if 
there was delay in imaging for whatever reason, it became difficult to code the 
clinical event in the knowledge that either coding category - ‘clinically probable 
haemorrhage’ or ‘true focal neurological deficit without imaging support’ were 
possible truths. The inevitable overlap between these two groups is difficult to 
overcome and is why I have analyzed the pertinent data on presentation, and also 
prognosis in the chapter that follows, in two ways. I felt analyzing results with 
haemorrhages in a group alone was too simplistic and missed out on part of the story 
of cavernomas. Putting haemorrhages and focal neurological deficits together in an 
analysis appears to be justified by the statistically significant finding that women are 
more likely to present with haemorrhage or focal neurological deficit than men. 
 
 If I could do it all over again, I think that our clinical event, ‘focal neurological 
deficit’, could be more clinically relevant if we had refined our coding into ‘non 
haemorrhagic focal neurological deficit’ and ‘focal neurological deficit not otherwise 
specified’, the distinguishing feature being timely imaging supporting or refuting the 
presence of haemorrhage. This clarity would facilitate analysis in SIVMS but also 
between SIVMS and any other similar studies in the future. 
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Not only is SIVMS the only prospective population-based study but it also has the 
largest number and proportion of sporadic, asymptomatic cavernomas in the 
literature (n = 65, 47%). It is interesting that asymptomatic cavernomas tended to 
present slightly later but, as I will show in the subsequent chapter on prognosis, it 
doesn’t appear that overall this presentation indicates a more benign clinical course. 
 
In symptomatic presentations in SIVMS, the ranking of epilepsy, focal neurological 
deficit and haemorrhage in decreasing order of frequency is probably as one would 
expect in a population-based study. The dramatic and sudden effect that haemorrhage 
can have on an individual’s life can sometimes overshadow the fact that the greater 
population burden is due to epilepsy. It is important to highlight this, as a diagnosis 
of epilepsy can have huge implications for a young adults life, not to mention the 
possible side effects of medical therapy to treat it. Also, epilepsy due to a structural 
abnormality tends to be more pharmacoresistant. Many earlier studies focused on 
those presenting with haemorrhage, perhaps now we should address more closely the 
issues that epilepsy raises for patients with cavernomas.    
 
Fourteen percent  (n = 19) of the cohort had multiple cavernomas. It is sobering that 
the literature suggests many of these are likely to have a familial form of the disease. 
Currently there is no policy to screen patients of relatives with multiple cavernomas. 
How this should be addressed in an observational study is an interesting question. 
One of the key considerations should probably be – what is the risk of significant 
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morbidity or death in relatives of those with multiple CMs? This could be the subject 
of a whole other thesis! 
 
Again fourteen percent (n = 20) of the SIVMS cohort had an accompanying venous 
malformation. The significance of this is mainly in terms of technical complexity of 
surgery. It doesn’t appear to have significant impact on the mode of presentation. 
 
In conclusion, this data from SIVMS adds to the quality of evidence in the literature 
about cavernoma natural history. 
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Chapter 6:  
The prognosis of intracranial cavernous malformations in 
SIVMS 
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6.1 Introduction 
As I have mentioned previously, it was the study design of SIVMS that made the 
assembled cohort a valuable resource for analyses such as prognosis. I will first 
summarise the procedures for follow-up in SIVMS and then will look at the 
prognosis. 
The cohort of patients used in this analysis were those recruited to SIVMS between 
January 1
st
 1999 and December 31
st
 2003. The follow-up data used in the analysis 
was that available to me on 31
st
 August 2004. 
 
6.2 Annual follow-up procedures in SIVMS 
Patients were followed up on an annual basis during their lifetime by SIVMS using 
several overlapping methods. 
 
Every patient's GP was contacted six weeks before the anniversary of the patient's 
diagnosis. A single page GP questionnaire sought confirmation of the patient's 
address and enquired about whether they were still suitable for postal contact, or 
whether it was now appropriate to send a postal consent pack if it had not been 
before. The questionnaire also asked about hospital visits/admissions in the 
preceding year, the occurrence of brain haemorrhage and epilepsy, and asked the GP 
to assess the patient's current disability on the modified Rankin scale [Bamford, 
1990], [Appendix 8]. A reminder letter was sent after three weeks [Appendix 9], and 
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GPs were telephoned after a further three weeks if they still had not replied. A copy 
of the GP casenotes amassed over the last year and also copies of casenotes from any 
hospital visits were reviewed by the SIVMS Research Fellow and any relevant 
outcomes were recorded in the database. 
 
Patients were contacted directly, if appropriate, about the occurrence of headaches 
and seizures or fits [Appendices 10, 11 & 12]. When a patient died a copy of the 
patient’s death certificate was obtained from the GRO and an autopsy report 
requested if a post-mortem was performed. 
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6.3 Assessment of disability in SIVMS; Modified Rankin scale  
This well established scale for quantifying the morbidity associated with many 
medical conditions was recorded at presentation by the Research Fellow from 
information available in the casenotes. Thereafter it was recorded annually for 
patients in SIVMS where possible based on the GP or patient annual questionnaire 
[Appendices 8 & 10]. 
 
Table 19 Modified Rankin Scale 
Symptom level Score 
No symptoms 0 
Minor symptoms, which do not interfere with lifestyle 1 
Some restrictions to lifestyle but looks after oneself 2 
Significant restriction to lifestyle, preventing total independence 3 
Severe handicap preventing independent existence, but not requiring 
constant attention 
4 




The nature, frequency and natural history of intracranial cavernous malformations in adults 
 
The prognosis of intracranial cavernous malformations in SIVMS  111 
 
6.4 The prognosis of cavernomas in SIVMS 
I used Kaplan Meier analysis and survival plots to illustrate the survival and ‘time to 
event’ data for the patients in SIVMS. SPSS version 16.0 software was used to 
conduct these analyses.  
In the analysis patients were censored at the relevant date of outcome, date of death 
or date of last follow-up. 
 
6.4.1 Prognosis analysis using primary outcomes 
6.4.1.1 All cause mortality  
Six patients presented dead and during follow-up eight more patients died. Of those 
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6.4.1.2 Death due to cavernoma alone  
One of the three deaths due to cavernoma had been treated with surgical excision. 
Their death was almost two years after surgery and was due to a seizure (Treatment 
6/3/02, death 2/1/04). The seizure disorder also predated their surgery. 
The second death was due to choking precipitated by haemorrhage from the 
cavernoma.  
The final death was due to a chest infection as a consequence of a persistent focal 
neurological deficit caused by the brainstem cavernoma. 
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6.4.1.3 First or recurrent haemorrhage during follow-up due to cavernoma 
Six patients had a haemorrhage after presentation. One of these six patients had two 
haemorrhages during follow-up. 
Five out of the six haemorrhages were in women. 
Treated patients were not censored at their treatment date in this graph. Two patients 
who haemorrhaged were treated but this was after their haemorrhage had occurred 
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6.4.1.4 FND during follow-up in all cavernomas 
Treated patients were not censored at their treatment date in this graph. Five of the 
nineteen patients who had FNDs were treated. Four of those five were treated before 
the FND but very close in time to it. One was treated after the FND had occurred. 
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6.4.2 Prognosis analysis using composite outcomes and stratifying features 
In this section I use the composite outcome of haemorrhage and focal neurological 
deficit. The logic of this was discussed in Chapter 5 on presentation and the same 
logic holds true here for outcomes. 
 
6.4.2.1 The outcomes during follow-up; Haemorrhage and haemorrhage/FND stratified 
by asymptomatic versus symptomatic presentation 
My analysis of presentation showed that asymptomatic cavernomas presented a 
decade later than symptomatic ones. This led me to pursue whether asymptomatic 
cavernomas have a more benign clinical course. I therefore investigated any 
statistical differences that could be demonstrated between the number of 
haemorrhage or haemorrhage/FND outcomes seen in the asymprtomatic versus 








The nature, frequency and natural history of intracranial cavernous malformations in adults 
 
The prognosis of intracranial cavernous malformations in SIVMS  116 
 
Figure 15 Haemorrhage during follow-up in asymptomatic versus symptomatic 
presentations
 
Figure 16 Haemorrhage/FND during follow-up in asymptomatic versus 
symptomatic presentation
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Both figures illustrate the finding that there was no significant, or indeed clinical 
difference between the survival curves in the asymptomatic presentation versus the 
symptomatic presentation groups despite the statistically significant difference in 
mean age at presentation. 
 
6.4.2.2 First or recurrent haemorrhage or FND during follow-up stratified by 
haemorrhagic presentation versus other presentation  
Treated patients were not censored at their treatment date in this graph.  
Three patients who had FNDs were treated. Of those three one surgical excision was 
performed after the FND occurred and the other two had surgical excision prior to 
the occurrence of their FND although the surgery and FND were very close in time. 
Two patients who haemorrhaged were treated by surgical excision but this was after 
their haemorrhage had occurred. 
Mantel-Cox Log Rank test was used for comparison of survival curves between 
those presenting with haemorrhage and those not. There was no statistically 
significant difference (p = 0.103) although the number of cases presenting with 
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Figure 17 Haemorrhage/FND during follow-up stratified by haemorrhagic 






6.4.2.3 First or recurrent haemorrhage or FND during follow-up stratified by 
haemorrhagic/FND presentation versus other presentation  
Treated patients were not censored at their treatment date in this graph. Three 
patients who had FNDs were treated. Of those three one surgical excision was 
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performed after the FND and the remaining two had surgical excision prior to the 
occurrence of their FND although the surgery and FND were very close in time. 
Two patients who haemorrhaged were treated by surgical excision but this was after 
their haemorrhage had occurred. 
Mantel-Cox Log Rank test was used for comparison of differences in survival 
curves between those presenting with haemorrhage or FND and those not. There was 
a significant difference (p < 0.05). 
 
Figure 18 Haemorrhage/FND during follow-up stratified by haemorrhage/FND 
presentation versus other 
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6.4.2.4 First or recurrent haemorrhage or FND during follow-up stratified by gender 
In Chapter 5 it was shown that women were statistically more likely to present with 
haemorrhage or focal neurological deficits. When this was combined with the information in 
figure 18 illustrating a significant difference in the survival curves in terms of the composite 
outcome haemorrhage/FND for those presenting with haemorrhage/FND or not, I wondered 
whether this difference in survival curves for the composite outcome would also be true if it 
was examined for gender. Knowledge that five out of six haemorrhages and fourteen out of 
nineteen FNDs were in women added to my curiosity.  
 
Figure 19 Haemorrhage/FND during follow-up stratified by gender 
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Mantel-Cox Log Rank test was used for comparison of differences in survival 
curves between males and females for the composite outcome haemorrhage/FND. 
There was a significant difference (p < 0.05). Women appeared to have a greater 
statistical chance of haemorrhage or FNDs than men. 
 
6.4.3 Disability in SIVMS 
6.4.3.1 SIVMS Modified Rankin scores at presentation and at 1 year  
At presentation 13% of the cohort had a Modified Rankin score of ≥3. 
For all modes of presentation table 21 illustrates the amount of significant disability 
in the SIVMS cohort at the end of the first year after presentation as assessed by the 
modified Rankin scale. 
 
At the end of year one, 16% of the cohort had a Rankin of ≥ 3. Rankin scores were 
missing for 13 patients all of whom had not reached their first anniversary prior to 
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Table 20 Modified Rankin score 1 year after presentation 
Rankin N % 
0 45 32% 
1 26 19% 
2 34 24% 
3 10 7% 
4 1 1% 
5 2 2% 
Dead 8 6% 
Missing data 13 9% 
 
Overall the disability burden in the cohort does not appear to have changed in one 
year into follow-up. 
 
6.5 Discussion 
As my systematic review highlighted, calculating simple rates of outcomes for 
patients with cavernomas can be misleading and unhelpful. A particular, 
insurmountable difficulty is to do with the unknown date of biologic onset. I propose, 
therefore, that Kaplan Meier analysis/survival curves of early prospective follow-up, 
which can also factor in censored patients, is a much more meaningful way of 
looking at prognosis after presentation in this population.  The useful conclusions 
that we were able to draw for patients with cavernomas from our prospective, 
population-based data is as follows:  
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 All cause mortality – three years after presentation 87% of the cohort were 
alive 
 Death due to cavernoma –  the three deaths in SIVMS during follow-up, 
known to be caused by the cavernoma, were evenly distributed between 
haemorrhage, epilepsy and focal neurological deficit. 
 First or recurrent haemorrhage during follow-up – two years after follow-up 
94% of the cohort were haemorrhage free 
 Focal neurological deficit (FND ) – three years after presentation 80% of the 
cohort were FND free 
 Being female or presentation with the composite event - haemorrhage or FND 
-  had a statistically significant impact on making one more likely to either 
haemorrhagic or FND outcomes during early follow-up. 
 Asymptomatic presentation appeared to have no impact on the likelihood of a 
haemorrhagic or FND outcome during early follow-up. 
 Haemorrhagic presentation alone also appeared to have no statistical impact 
on the likelihood of a haemorrhagic or FND outcome during early follow-up. 
 In our cohort, the proportion of patients with a modified Rankin sore of ≥ 3 
did not change significantly between presentation (13%) and the end of year1 
(16%). 
 
The nature, frequency and natural history of intracranial cavernous malformations in adults 
 
The prognosis of intracranial cavernous malformations in SIVMS  124 
 
Our data would seem to suggest that most haemorrhages or focal neurological 
deficits that occur during follow-up appear to occur in the two to three years after 
presentation and then events seem to plateau. At three years follow-up however, our 
numbers are very small and therefore this finding is unsound. As SIVMS continues 
follow-up this will be an interesting trend to observe. 
 
Being female or presentation with haemorrhage or FND predict poorer outcome in 
terms of haemorrhage or FND in early follow-up. These factors may well be 
interrelated. In Chapter 5 we found women were more likely to present with 
haemorrhage or FNDs than men. That aside, our finding supports the literature to 
date that there is a hormonal effect putting women at greater risk of haemorrhage 
than men (section 1.1.3). The mechanism of how this happens is still unproven 
however. 
 
In Chapter 5 I discussed the logic of amalgamating haemorrhagic outcomes with 
FNDs. There is clear overlap between the two groups but not complete overlap. 
Therefore, as I mentioned previously, I think a more clinically relevant outcome 
would be ‘definite non haemorrhagic FND’ and ‘FND with no timely imaging’. This 
is what has been proposed by the Angioma Alliance Scientific Advisory Board in 
2008 [Al-Shahi, 2008]. This would aid sensitivity analysis within SIVMS and also 
between similar studies.   
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Another final observation from our cohort is that being asymptomatic at presentation 
is of no benefit in terms of subsequent prognosis of haemorrhage or FND. This is an 
important observation as to date most patients selected for treatment are those with 
haemorrhagic presentations or intractable epilepsy. Our results suggest that this is not 
logical.  
 
SIVMS has provided an invaluable dataset for establishing the early prognosis of 
patients with intracranial cavernous malformations. Since the conclusion of the 
dataset used for this thesis, follow-up of our cohort has been continued by others who 
became involved with SIVMS after my period as Research Fellow. This completed a 
full 5 years follow-up on each patient and culminated in a recent publication in 
Lancet Neurology [Al-Shahi et al, 2012]. Longer follow-up confirmed the trends 
suggested by my data that recurrent events such as haemorrhage and focal 
neurological deficit appear to cluster in the first couple of years after presentation 
and then the risk tapers off (the annual risk of recurrence of this composite outcome 
declined from 19·8% (95% CI 6·1–33·4) in year 1 to 5·0% (0·0–14·8) in year 5) and 
the risk of a recurrent event is higher for women than men (p=0∙01). Also the 5 year 
risk of a first ever composite outcome such as this was significantly less than the 5 
year risk of a recurrent outcome (9·3%, 3·1–15·4 vs 42·4%, 26·8–58·0; p<0·0001). 
The follow-up continues.  
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Chapter 7:  
The treatment of intracranial cavernous malformations in 
SIVMS 
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7.1 Introduction 
As discussed in Chapter three, there are no randomised controlled studies of 
treatment in cavernous malformations. This thesis focuses on the untreated clinical 
course or natural history of cavernomas, However, some of our 139 patients were 
treated, but as SIVMS was an observational study we had no impact on who or how 
this came about. For information, I will detail how these patients were managed but 
no real conclusions can or will be drawn from these data. 
 
7.2 Treatment of cavernomas in SIVMS 
Twenty-four patients in all were treated in our cohort. Twenty-three were treated 
with complete surgical excision, one with partial surgical excision and none with 
Gamma-knife radiosurgery. 
The decision to go for treatment was made by the clinician and patient together. 
SIVMS had no input into this.  
The average time from presentation to treatment was 303 days. 
Of the 24 patients who were treated in SIVMS their breakdown in terms of mode of 
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Table 21 Mode of presentation of patients treated in SIVMS 




Focal neurological deficit 3 
 
Four centres offer neurosurgery in Scotland, the breakdown in location where the 
surgery took place is shown in table 23. 
 
Table 22 Numbers of patients treated subdivided by neurosurgical centre 
Neurosurgical centre Number of patients 
undergoing surgery for 
their cavernoma (as a % 
of those treated) 
% of the population 
residing within the 
catchment area 
Centre A 3 (12%) 8% 
Centre B 13 (54%) (All 4 incidental 
cases were treated here) 
49% 
Centre C 4 (17%) 13% 
Centre D 4 (17%) 30% 
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7.3 Discussion 
SIVMS was an observational study and of our 139 patients included for prospective 
follow-up, 24 were treated. It is interesting to note that all of these patients were 
treated with surgical excision and none were treated with radiosurgery (although it is 
available). Is this because the clinicians responsible were neurosurgeons and more 
confident in offering a treatment they could deliver themselves? Or the fact that 
patients would have to cross the border to England for radiosurgery had some impact 
on the decision process? No matter, the decision to treat was clearly a subjective one. 
With this in mind and also the small numbers I felt it inappropriate to segregate out 
treated patient for analysis of prognosis. I felt the data would be misleading and 
unhelpful and would simply add to the methodologically unsound literature already 
published. 
 
Reported high re-haemorrhage rates in those presenting with haemorrhage, or 
epilepsy refractory to medical management, are the two reasons usually cited in the 
literature as an indication for surgical intervention. In our cohort, of the six patients 
who haemorrhaged during the early, prospective follow-up period, three of them had 
presented to the study with an incidental diagnosis, two had presented with 
haemorrhage and one with a focal neurological deficit. This raises doubt about the 
selection criteria (predictors of poor prognosis) used for surgical intervention in the 
literature to date. Also the spread of presentations across the treated patients in 
SIVMS (table 22) further highlights the lack of uniformity or evidence based 
decision making that occurs between centres.  
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The proportions of patients treated according to neurosurgical centre are broadly in 
line with the populations of the relevant catchment areas. There is a slight 
discrepancy between the two middle-sized centres. This could be due to regional 
differences in practice but is most likely a spurious finding with such small numbers. 
 
In conclusion, evidence regarding the best way to manage patients with cavernomas 
is scant and the treatments available are not without risk. It is therefore imperative to 
establish the untreated prognosis of cavernomas so we can proceed to uncovering 
who is best to treat and with what treatment, short of any randomized controlled 
trials. 
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Chapter 8:  
Validity of MR imaging in the diagnosis of intracranial 
cavernous malformations 
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8.1 Introduction 
The relative contribution of the main imaging modalities (cerebral angiography, CT 
and MR imaging) to the diagnosis of intracranial cavernous malformations is clear 
from my introduction in Chapter 1. Anecdotal evidence in the literature supports the 
theory that MR is superior to CT and angiography combined in the diagnosis of 
cavernomas. However, as MR imaging is currently used as a screening tool in the 
familial cavernoma setting I felt it was important to evaluate it as a stand-alone 
investigation to see whether it could rival histology as a mode of diagnosis. There is 
no doubt that a non-invasive imaging test providing a definite diagnosis is superior to 
an excision biopsy or post-mortem specimen but only if it is of adequate sensitivity 
and specificity. The sensitivity and specificity of MR imaging was therefore 
important to quantify. Some of the cases included in this study came from SIVMS 
but that is where the overlap ended. The study design, execution and analysis were 
separate from SIVMS and will be outlined in the following sections. 
 
8.2 The validity of MR imaging in the diagnosis of intracranial cavernomas; 
methods 
The study design was to compare the sensitivity and specificity of MR in true, 
pathologically verified cavernous malformations versus commonly encountered 
mimics. 
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8.2.1 Cavernoma cases 
Pathologically verified cases of intracranial cavernous malformations were sought 
from the four neuroscience centres in Scotland – Aberdeen, Dundee, Edinburgh and 
Glasgow. Consent was obtained from the attending consultant to review the pre-
operative imaging of each case. Any individual who also had a pre-operative 
magnetic resonance scan in the last ten years was included in this study. Cases from 
the SIVMS study were also included. Seventeen cases, with a total of nineteen 
cavernous malformations, fulfilled all the selection criteria. 
8.2.2 Mimic cases 
Mimics were more difficult to select. A literature search identified the lesions most 
likely to be confounders in the radiological diagnosis of cavernomas of the brain 
[Preul, 1992] & [Olivero, 2000], [Akimoto, 2009], [Becker, 2010], [Buccoliero, 
2006], [Bulzico, 2011], [Matsuno, 2005] (table 24). 
Table 23 Mimics of cavernomas in the literature 





Choroid plexus papillomas 
Other tumours (astrocytomas, gliomas, etc.) 
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The MR scans of cases with any one of these six diagnoses were then selected from 
imaging libraries accessible to us. Fifty-six cases were identified and given to an 
independent neuroradiologist (Dr AJ Farrall) to select the best cases for our study. 
The criteria he sought were MR scans done within the last 10 years whose lesion 
characteristics on MR imaging would represent the cases a neuroradiologist may find 
difficult to interpret as a definite cavernous malformation. Eleven cases met with 
these criteria. The confirmation of the correct diagnosis in each case was made by 
pathology after surgical excision/biopsy or by follow-up imaging over a significant 
period of time. The mimics used in this study fell into the following categories (table 
25). 
 
Table 24 Mimics used in validity of MR study 
Diagnosis of mimics used in study 
1 Solitary metastasis 
1 CSF cyst 
6 Spontaneous haematoma  
2 Arteriovenous malformation with haematoma 
1 Radiation induced vascular abnormality 
 
No MR scan pre-dated 1992. As the cases were ascertained retrospectively, and from 
different centres, the sequences done varied from case to case. We decided therefore 
that sequences common only to all scans (T1 and T2) should be used for this study. 
The distribution of sequences used by the reviewing radiologists for both groups are 
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shown in tables 26 and 27 respectively. Originally we assumed that most cases 
would have included a gradient echo sequence; however only 7 of our 28 scans had 
this sequence done as part of the original diagnostic workup. This was too few to 
include in the study and therefore any gradient echo sequences were removed from 
the study packets for review. 
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Table 25 Sequences for cavernomas available for use 
Table of sequences available for cavernous malformations 
1 T1 sagital, T1 axial T2 axial 
2 T1 axial T2 axial 
3 T1 sagittal, T1 coronal,  T2 axial 
4 T1 sagittal T2 axial, T2 coronal 
5 T1 sagittal, T1 coronal  T2 axial 
6 T1 axial+contrast, T1 sagittal+ contrast  T2 axial 
7 T1 coronal  T2 axial 
8 T1 axial T2 axial 
9 T1 coronal T2 axial 
10 T1 sagittal  T2 axial 
11 T1 sagittal  T2 axial 
12 T1 coronal T2 axial 
13 T1 axial  T2 axial 
14 T1 coronal  T2 axial 
15 T1 coronal  T2 axial 
16 T1 coronal, T1 axial T2 axial 
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Table 26 Sequences for mimics available for use 
Table of sequences available for mimics/controls 
18 T1 axial, T1 axial + contrast T2 axial 
19 T1 axial, T1 sagittal, T2 axial 
20 T1 axial + contrast T2 axial 
21 T1 axial + contrast T2 axial 
22 T1 axial, T1 sagittal T2 axial 
23 T1 sagittal T2 axial 
24 T1 sagittal T2 axial 
25 T1 axial T2 axial 
26 T1 sagittal T2 axial 
27 T1 sagittal T2 axial 
28 T1 axial T2 axial 
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All cases were unknown to our reviewing radiologists. The observers were five 
neuroradiologists (table 28) from different centres in England, all of whom had a 
special interest in vascular abnormalities of the brain. They reviewed independently 
of each other. 
 
Table 27 The five reviewing neuroradiologists from England and Wales 
Hospital base Neuroradiologist 
Atkinson Morley’s Hospital,  London A Clifton 
Newcastle General Hospital, Newcastle 
upon Tyne 
A Gholkar 
University Hospital of Wales, Cardiff S Halpin 
Radcliffe Infirmary, Oxford A Molyneux 





8.2.3 Data collection 
Hard copies of all 28 scans (30 lesions) were sent to the individual reviewers with a 
standard data collection form to be completed for each scan [appendix 11]. Each 
reviewer was asked to answer the following questions; 
 What is the quality of the film? 
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 Are there any lesions with imaging characteristics of a cavernous 
malformation? 
 If answer yes, what side and area of the brain is it in? 
 Is it a definite cavernous malformation, a maybe or a definitely not 
cavernous malformation? 
 If the maybe option was chosen they were asked what they would like 
to do next to confirm the diagnosis? 
The data were recorded in a Microsoft Access database. All data were double-
punched to ensure accuracy of data entry.  
 
8.2.4 Data processing and analysis 
Calculating the sensitivity and specificity of MR imaging as a diagnostic tool for 
cavernomas requires a dichotomous dataset. In this study each reviewer was given 
three options for each lesion – definite yes, maybe and definite no. This was done to 
reflect, as accurately as possible, the real life diagnostic dilemma faced by clinicians. 
Therefore when calculating the sensitivity and specificity of MR imaging it was 
analysed in two ways. 
 
Firstly, what we termed the harsh analysis. When a neuroradiologist prevaricated 
and chose the maybe option, it was assumed, for that lesion, even if they received the 
further imaging, which could be requested at this stage, they still got the diagnosis 
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wrong and the answers for maybe lesions were distributed as though they chose 
incorrectly between the two groups – definitely yes and definitely no. Now we had a 
dichotomous dataset to analyse which, in essence, reflected the worst possible 
scenario for sensitivity and specificity. 
 
In practice this situation is unrealistic. If a radiologist is unsure from the scan in hand 
what a lesion is, it is common and good practice to do further sequences, or follow-
up imaging which clarifies the diagnosis. To reflect this scenario, the more fair 
analysis gave each reviewer the benefit of the doubt and assumed that, if supplied 
with further sequences or follow-up imaging, they would have correctly diagnosed 
the lesion for what it was. The maybe group were therefore distributed correctly 
between the definitely yes and the definitely no groups. This in turn gives a best 
possible case scenario for sensitivity and specificity. 
 
The sensitivity and specificity of each reviewer were calculated. All analyses were 
performed in Statistical Product for the Social Sciences (SPSS) version 11.0 except 
confidence intervals which were calculated using Confidence Interval Analysis 
software [Altman, 2000].  
 
8.2.5 Ethics 
Every film was carefully anonymized in order to protect patient confidentiality and 
comply with UK Data Protection legislation. This study was covered under the 
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approval given for SIVMS by the Multicentre Research Ethics Committee for 
Scotland (MREC/98/0/48). 
 
8.3 The  validity of MR imaging in the diagnosis of intracranial cavernous 
malformations; Results 
The five reviewing consultant neuroradiologists from England each reviewed the 
identical twenty-eight MR scans (30 lesions). All sets of scans had a mixture of real 
cavernoma cases and mimics. The reviewers were not privy to the cavernoma: mimic 
ratio.  
 
A complete set of data was received from all reviewers. There was only little 
disagreement between reviewers about film quality and therefore the modal rating 
was taken. The results are shown in table 29. 
 
Table 28 Film quality 
Film quality % 
Good 18% (5/28) 
Average 68% (19/28) 
Poor 14% (4/28) 
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The distribution of lesions according to side and brain area are shown in table 30. 
There was no overtly dominant location that could account for easier or more 
difficult recognition of the lesion by the neuroradiologists.  
 
Table 29 Distribution of lesions by side and location 
 Cavernoma (19) Mimic (11) 
Left 58% (11) 45% (6) 
Right 42% (8) 55% (5) 
Supratentorial 
Frontal 4 2 
Frontotemporal 2 0 
Fronto-parietal 0 3 
Parietal 2 2 
Temporal 6 0 
Temporo-parietal 2 1 
Parieto-occipital 1 0 
Thalamus 1 2 
Occipital 0 1 
Infratentorial 
Cerebellum 1 0 
 
If the reviewing neuroradiologists could only give a ‘maybe’ diagnosis for the lesion 
in question, they were asked to choose what further sequences they would request in 
a real clinical setting to confirm the diagnosis. Table 31 illustrates the distribution of 
their choices. 
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Table 30 Frequency with which reviewers requested different sequences 
Sequence Number of requests Frequency of request (%) 
T1 16 14 
T2 16 14 
FLAIR 12 12 
PD 5 5 
T1 + contrast 20 17 
Gradient echo 35 31 
Angio 12 10 
Diffusion 0 0 
MRA 0 0 
 
 
As discussed in section 8.2.4 the sensitivity and specificity analysis of this dataset 
was calculated in two ways – harsh and fair.   
The harsh and fair analyses are shown in tables 32 & 33 respectively. The harsh 
dataset yielded a mean sensitivity of 58% and a specificity of 67% (Table 32). The 
fair analysis which is akin to a genuine clinical setting yielded a specificity of 100% 
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1 74(51-88) 64(35-84) 
2 47(27-68) 100(74-100) 
3 68(46-87) 64(35-84) 
4 53(32-73) 36(15-64) 
5 47(27-68) 73(43-90) 
mean 58 67 
 





1 84(62-94) 100(74-100) 
2 68(46-84) 100(74-100) 
3 89(69-97) 100(74-100) 
4 100(83-100) 100(74-100) 
5 74(51-88) 100(74-100) 
mean 83 100 
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8.4 Discussion 
This study was a pragmatic effort to quantify sensitivity and specificity of MR 
imaging as a stand-alone diagnostic tool for cavernomas of the brain. This was the 
first study of its kind. Many studies have confirmed the superiority of MR imaging 
over CT imaging or cerebral angiography as a diagnostic tool [Rigamonti, 1988], 
[Requena, 1991] and there is general acceptance among the radiology community 
that MR imaging, in particular scans incorporating gradient echo sequences, are the 
gold standard for diagnosis of brain cavernomas [Brunereau, 2001], [Haque, 2003] 
and [Lehnhardt, 2005]. This study however shows that, even in the most optimistic 
clinical setting, although MR is highly specific (mean 100%) sensitivity (mean 83%) 
still falls short of pathological verification. The disappointing results of our harsh 
analysis- sensitivity 58% & specificity 67% - probably reflected the inadequacy of 
T1 & T2 sequences alone.  
 
In this study we focussed solely on the comparison of MR against histopathology as 
a diagnostic tool. Of course both these tests require human input to interpret and are 
therefore subject to human error or differences in abilities between reviewers. 
Attempts are often made in studies of this nature to quantify how well 
reviewers/observers agree with each other as opposed to agreement arising by chance 
and conclude from this data something about the robustness of the technique as a 
diagnostic tool. The kappa statistic is commonly used in the literature for this 
purpose. However, I did not apply this here because kappa is confined to comparing 
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two reviewers and our study had five (i.e. ten kappa statistics would be required). To 
do multiple kappas would have been unwieldy and difficult to interpret in a 
pragmatic way. There are statistical tests such as the Fleiss kappa which can be done 
with multiple reviewers but after discussion with our statistician, Dr S Lewis, I 
concluded that this was a pragmatic study with other methodological limitations and 
to attempt more complex evaluation of interobserver reliability would simply detract 
from the main messages of the study, firstly, that MR is an excellent diagnostic tool 
and secondly that gradient echo or SWI imaging should be added to the protocol in 
assessment of potential intracranial cavernomas. 
 
The ideal circumstances in which this type of study should be executed are very 
difficult to create – prospective ascertainment of both real, histologically confirmed 
cases and mimics, standard and reproducible MR study protocols, use of identical 
scanners and multiple reviewers with little inter-observer variation. 
 
 The obvious disadvantage of our retrospective study, is the possibility that the real 
cases we chose were sent for surgical excision because they presented a diagnostic 
conundrum. This would account for the poor sensitivity (mean 58%) in the harsh 
analysis. Added to this, a retrospective study limits one to the sequences done at the 
time of investigation and thus inhibits standardisation of the image sequences and 
image quality. Although we tried to minimise this as much as possible by restricting 
studies to the last ten years, both factors affecting the reviewers’ diagnostic decision, 
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are outside our control. In a prospective study all suspected cavernous malformations 
would undergo an agreed protocol of sequences, on an identical scanner, and all 
suspected cases would be included. As long as a true diagnosis could be reached in 
all cases, the non-cavernous malformations would be ideal mimics. In this study, 
mimics also had to be selected retrospectively, which encountered the same 
disadvantages as the real cases. An added hindrance was their subjective selection, 
allowing us to make them as easy or as difficult as we liked. Clearly, this could alter 
the results in either direction. In reality we tried to make them as reasonable and 
realistic as possible but, unfortunately, we could not avoid subjective methods of 
selection. As is evident from table 25 a disproportionate number of our mimics were 
spontaneous haematomas. Clearly follow-up imaging would be likely to clarify the 
true diagnosis. These were predominantly the cases that lead to the maybe group as 
an answer. Figures 20 and 21 are examples of images from the study. Figure 20 is a 
haematoma with an underlying cavernous malformation and figure 21 is a 
spontaneous haematoma without an underlying CM. The similarity of these images 
illustrate the limitations of basic sequences at a single point in time. This clinical 
scenario is faced by radiologists all the time and it explains why further, delayed 
imaging is often sought. As the haematoma contracts and reorganises an underlying 
abnormality will become visible. This gives further credence to our arbitrary decision 
to assume reviewers would have got the correct diagnosis if they had further follow-
up imaging available.  
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Figure 20 Spontaneous haemorrhage in a cavernoma. 
 
Figure 21 Spontaneous haemorrhage without an underlying cavernoma. 
 
Cavernous malformations are a relatively uncommon condition, the incidence being 
approximately 0.67(95% CIs, 0.56 to 0.79) per 100,000 adults per year and therefore 
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the reality of gathering cases prospectively in sufficient numbers would be almost 
impossible. With these limitations in mind, while this study is not a gold standard, it 
does give a valuable estimate of the sensitivity and specificity of a diagnostic tool 
that is rapidly overtaking other modalities as the investigation of choice for lesions 
such as brain cavernous malformations. Our results also go part way towards 
justifying the use of MR as a screening tool in relatives of those afflicted with the 
familial form of cavernous malformation. 
 
With advances in technology the multiple functions or sequences of MR scanners are 
developing faster than we can rationalise what sequences are best for what 
conditions. Protocols are constantly being refined to the most suitable regime to aid a 
diagnosis. Therefore it is important to have an indication of the possible diagnosis 
prior to the investigation. It is not practicable, or necessary, to do all sequences on all 
patients. Recently in the literature it has been suggested that gradient echo sequences 
are now an integral part of a basic investigation for a cavernoma. In our study, 
however, we were surprised to find that only seven out of twenty-eight possible cases 
had this done. Gradient echo (GRE) was a popular request by the neuroradiologists 
in the maybe group and, perhaps, a study of this kind should be repeated with and 
without GRE sequences (see Table 31). 
 
In conclusion, while MR has some limitiations (imperfect sensitivity) as a diagnostic 
tool, in the real world it is a valid screening tool for familial cavernomas and also as 
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a diagnostic tool for inclusion in studies such as SIVMS. Users need to bear in mind 
however the importance of informing the radiologists supervising the studies of the 
potential diagnosis as sequences performed during the scan will be tailored 
accordingly and will likely have a significant effect on how useful the study will be 
as a diagnostic tool. 
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9.1 Conclusion 
My systematic literature review supported my, and the SIVMS steering committee, 
view that there was little high quality evidence in the public arena on the 
epidemiology and natural history of intracranial cavernous malformations in adults. 
The setting up of SIVMS as the first prospective, population-based study of an 
inception cohort has changed this completely. The robust study design has facilitated 
this thesis by providing an excellent cohort of patients in whom I could study the 
epidemiology, presentation and untreated clinical course of this disease. This has not 
been done before. 
 
This thesis does not answer all questions about intracranial cavernomas. In fact, it 
highlights some areas where improvements could be made by refining our clinical 
event definitions. It also suggests trends in the data not anticipated and that cannot be 
conclusively studied just now, but are important trends to monitor over time as this 
cohort of patients continues to be followed up, and added to with prospective data 
from other studies in an individual patient data meta-analysis.   
 
We live in a world where clinical practice is, rightly, more and more dependent on 
evidence based medicine. This practice also provides patients with accessible 
information allowing them to be closely involved in decisions about their own 
treatment. The validity of MR imaging study fills a vacuum in this evidence base in 
terms of why clinicians now turn to MR as a diagnostic and screening tool for 
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intracranial cavernomas. Reliance on evidence rather than hunches supporting a 
clinician’s practice is a standard that patients expect from their clinicians today. 
 
The salient conclusions for intracranial cavernous malformations in adults arising 
from this thesis are 
 An estimated incidence of 0.67(95% CIs, 0.56 to 0.79) per 100,000 adults per 
year 
 For a population the size of Scotland, approximately 5.2 million, our results 
predict that approximately twenty-nine new cases of brain cavernomas in 
adults are diagnosed each year. 
 The incidence of asymptomatic cavernomas is only slightly less than 
symptomatic CMs, with overlapping confidence intervals - 0.24(95% CIs, 
0.24 to 0.4) versus 0.36(95% CIs, 0.28 to 0.45) per 100,000 adults per year. 
 Asymptomatic cavernomas present on average a decade later than 
symptomatic cavernomas. They do not appear to have a more benign clinical 
course after diagnosis however. 
 The modes of presentation in a population in decreasing order of frequency 
are; asymptomatic (47%), epilepsy (25%), FND (15%) and 
haemorrhage(13%) 
  Women are more likely to present with haemorrhage or focal neurological 
deficit (FND) 
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 Presentation with haemorrhage or FND predicts a poorer outcome in terms of 
more haemorrhage or FND during follow-up 
 Women also have a poorer outcome in terms of more haemorrhage or FND 
during follow-up 
 MR imaging is a valid diagnostic tool for cavernomas although it is still less 
perfect than the gold standard of histopathology. Its precision would be 
improved by tailoring of sequences and appropriate timing of scans. 
Interesting trends in the data 
 Haemorrhages and FNDs appear to cluster in the 2 to 3 years after 
presentation 
 
9.2 The future 
This established cohort of patients has been continuously, prospectively followed-up 
even since my term as the SIVMS Research Fellow finished. While I have analysed 
the presentation and early follow-up of these patients, it will be very exciting to see 
the results of longer term follow-up on the cohort. In particular the trend emerging in 
my data of a clustering of events in the early post presentation period will be better 
assessed with more lengthy follow-up. 
 
SIVMS, with it’s robust study design, could serve as a prototype for other studies of 
the natural history of intracranial cavernomas. Unpicking the overlap between the 
The nature, frequency and natural history of intracranial cavernous malformations in adults 
 
Conclusion and future  155 
 
clinical events ‘haemorrhage’ and ‘FND’ by refining our definition of FND into ‘non 
haemorrhagic focal neurological deficit’ and ‘focal neurological deficit not otherwise 
specified’ as discussed in Chapter 5 would improve the quality of the data. Using 
these very clear, refined outcome definitions [Al-Shahi, 2008] would facilitate future 
sensitivity analysis within SIVMS and also between SIVMS and other studies 
adopting the same approach. 
 
My hope for the future is that once sound evidence of the untreated clinical course of 
these patients is established, then the research community will turn their attention 
towards identifying the subgroup of patients who would benefit from treatment. One 
never knows, perhaps a randomised controlled trial will happen!  
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Appendix 14 
See attached paper that follows. 
